syndrome	score	normalized_score
DEAFNESS, AUTOSOMAL DOMINANT 6	1.0232558	100.0
GOLDENHAR SYNDROME	1.02319335	99.99389693173494
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	1.0	97.72727405991736
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	1.0	97.72727405991736
OTOSCLEROSIS 7	1.0	97.72727405991736
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	97.72727405991736
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.75	73.29545554493802
DISTAL TRISOMY 15Q	0.50641026	49.49009426577401
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.5	48.86363702995868
%608645 DEAFNESS, AUTOSOMAL DOMINANT 31; DFNA31	0.5	48.86363702995868
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.5	48.86363702995868
ACATALASEMIA	0.5	48.86363702995868
DEAFNESS-EAR MALFORMATION-FACIAL PALSY SYNDROME	0.5	48.86363702995868
WRINKLY SKIN SYNDROME	0.5	48.86363702995868
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.5	48.86363702995868
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.5	48.86363702995868
INSULINOMA	0.3849209	37.61727028569005
RAMOS-ARROYO SYNDROME	0.3541663	34.61170706288691
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.33712088	32.945904631080516
AYME-GRIPP SYNDROME; AYGRP	0.33635421	32.870980061877
%109500 BASILAR IMPRESSION, PRIMARY	0.333333	32.575725444214434
FAMILIAL MEDIAN CLEFT OF THE UPPER AND LOWER LIPS	0.333333	32.575725444214434
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.333333	32.575725444214434
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.333333	32.575725444214434
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.333333	32.575725444214434
MOHR-TRANEBJAERG SYNDROME	0.3125	30.53977314372418
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.3055556	29.861115861742487
INSULIN AUTOIMMUNE SYNDROME	0.27777799999999997	27.14648673381572
8Q24.3 MICRODELETION SYNDROME	0.2588235	25.29411511764702
HYPERTRICHOSIS CUBITI	0.25641026	25.058275750794667
PGM3-CDG	0.25369004	24.7924360653514
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.25114939999999997	24.544146243783807
TERMINAL OSSEOUS DYSPLASIA; TOD	0.25	24.43181851497934
WEST SYNDROME	0.25	24.43181851497934
AMERICAN TRYPANOSOMIASIS	0.25	24.43181851497934
TETANUS	0.25	24.43181851497934
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.25	24.43181851497934
CONGENITAL ENTEROVIRUS INFECTION	0.25	24.43181851497934
TUFTED ANGIOMA	0.25	24.43181851497934
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.25	24.43181851497934
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.25	24.43181851497934
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.25	24.43181851497934
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	24.43181851497934
DYSTONIA 6, TORSION	0.25	24.43181851497934
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.25	24.43181851497934
HYPERPARATHYROIDISM 2	0.25	24.43181851497934
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.23448280000000002	22.915364857936794
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.23376609999999998	22.845323720618048
HEMIFACIAL MICROSOMIA	0.22317966	21.810739797419178
TRICHOTHIODYSTROPHY	0.2208333	21.581436430655952
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.216667	21.174275288740116
HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	0.2105263	20.57416141692038
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.20473934000000002	20.008617591026603
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.20238130000000001	19.77817276970236
7Q11.23 MICRODUPLICATION SYNDROME	0.20151745000000001	19.693751064005696
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.20151745000000001	19.693751064005696
AYMÉ-GRIPP SYNDROME	0.20150376	19.692413177623816
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	19.545454811983475
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.2	19.545454811983475
ROMANO-WARD SYNDROME	0.2	19.545454811983475
CAYLER CARDIOFACIAL SYNDROME	0.2	19.545454811983475
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.2	19.545454811983475
OTODENTAL SYNDROME	0.1899228	18.560637525826877
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.1825396	17.839097515987692
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.17630516	17.22982268949758
SARCOSINEMIA	0.17511509999999997	17.113521369729835
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.175	17.102272960485536
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.175	17.102272960485536
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.17287818000000002	16.894913275839727
GRANULOMATOSIS WITH POLYANGIITIS	0.16817076	16.43486995138459
PITYRIASIS RUBRA PILARIS	0.166667	16.28791158574425
PEMPHIGUS VULGARIS	0.166667	16.28791158574425
PFAPA SYNDROME	0.166667	16.28791158574425
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	16.28791158574425
HEREDITARY FRUCTOSE INTOLERANCE	0.166667	16.28791158574425
FECHTNER SYNDROME	0.166667	16.28791158574425
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.166667	16.28791158574425
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.166667	16.28791158574425
PROPROTEIN CONVERTASE 1/3 DEFICIENCY	0.166667	16.28791158574425
JERVELL AND LANGE-NIELSEN SYNDROME	0.16369029999999998	15.99700680905009
SCHINZEL-GIEDION SYNDROME	0.14759634	14.424187969420743
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.14654704	14.32164274074967
UNILATERAL POLYMICROGYRIA	0.14654704	14.32164274074967
HYDRANENCEPHALY	0.14285699999999998	13.961025190377613
ARNOLD-CHIARI MALFORMATION TYPE I	0.14285699999999998	13.961025190377613
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.14285699999999998	13.961025190377613
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.14285699999999998	13.961025190377613
DEAFNESS, AUTOSOMAL RECESSIVE 48	0.14285699999999998	13.961025190377613
DEAFNESS, AUTOSOMAL RECESSIVE, 24	0.14285699999999998	13.961025190377613
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.14285699999999998	13.961025190377613
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.14285699999999998	13.961025190377613
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.14285699999999998	13.961025190377613
%603964 DEAFNESS, AUTOSOMAL DOMINANT 16; DFNA16	0.14285699999999998	13.961025190377613
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 3	0.14285699999999998	13.961025190377613
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 46	0.14285699999999998	13.961025190377613
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.1400384	13.685571095712334
SLC35A2-CDG	0.1301938	12.72348517350207
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.12651745	12.364205509511892
HUNTINGTON DISEASE-LIKE 1	0.125	12.21590925748967
CHILDHOOD ABSENCE EPILEPSY	0.125	12.21590925748967
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.125	12.21590925748967
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.125	12.21590925748967
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.125	12.21590925748967
PRIMARY DYSTONIA, DYT13 TYPE	0.125	12.21590925748967
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.125	12.21590925748967
THORACOLARYNGOPELVIC DYSPLASIA	0.125	12.21590925748967
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.125	12.21590925748967
OCULAR MOTOR APRAXIA	0.125	12.21590925748967
PHENYLKETONURIA	0.125	12.21590925748967
CENTRAL PRECOCIOUS PUBERTY	0.125	12.21590925748967
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.12494001	12.210046598318817
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.12142860000000001	11.866886070912082
SECKEL SYNDROME 10; SCKL10	0.12059028000000001	11.784959342522173
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.1117424	10.920280148912912
RENAL AGENESIS, BILATERAL	0.11111099999999999	10.858575148071479
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.11111099999999999	10.858575148071479
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.11111099999999999	10.858575148071479
EPISODIC ATAXIA TYPE 4	0.11111099999999999	10.858575148071479
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.11111099999999999	10.858575148071479
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.11111099999999999	10.858575148071479
OGDEN SYNDROME	0.11111099999999999	10.858575148071479
FRAGILE X MENTAL RETARDATION SYNDROME	0.11111099999999999	10.858575148071479
HUNTINGTON DISEASE-LIKE 3	0.11111099999999999	10.858575148071479
AUTOSOMAL RECESSIVE ATAXIA DUE TO PEX10 DEFICIENCY	0.11111099999999999	10.858575148071479
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.11111099999999999	10.858575148071479
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.11111099999999999	10.858575148071479
SANDIFER SYNDROME	0.11111099999999999	10.858575148071479
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.10658909999999999	10.416662187499938
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.1055556	10.315661049759013
CLEFT LIP/PALATE-DEAFNESS-SACRAL LIPOMA SYNDROME	0.09731936000000001	9.51075576605576
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.09459914000000001	9.244916080612493
PELIZAEUS-MERZBACHER DISEASE	0.09242655000000001	9.032594782262656
PONTINE TEGMENTAL CAP DYSPLASIA	0.09241286000000001	9.031256895880777
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.09241286000000001	9.031256895880777
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.0909091	8.884298530240436
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.0909091	8.884298530240436
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.0909091	8.884298530240436
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.0909091	8.884298530240436
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.0909091	8.884298530240436
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.0909091	8.884298530240436
DEAFNESS, AUTOSOMAL RECESSIVE 28	0.0909091	8.884298530240436
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.0909091	8.884298530240436
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.0909091	8.884298530240436
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.0909091	8.884298530240436
YEMENITE DEAF-BLIND HYPOPIGMENTATION SYNDROME	0.0909091	8.884298530240436
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0909091	8.884298530240436
CONGENITAL ISOLATED ACTH DEFICIENCY	0.0900384	8.799207392716465
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.0844828	8.256273748949186
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.0844828	8.256273748949186
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.0844828	8.256273748949186
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.0844828	8.256273748949186
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.0844828	8.256273748949186
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.07809527000000001	7.632037854073244
WHITE-SUTTON SYNDROME; WHSUS	0.07638890000000001	7.4652789654356235
AICARDI SYNDROME; AIC	0.07634486	7.460975056286023
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.07444981	7.275776985578777
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.07317966000000001	7.151648688431574
TEMPLE SYNDROME	0.07142860000000001	6.9805223679162145
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.07142860000000001	6.9805223679162145
SILVER-RUSSELL SYNDROME	0.07142860000000001	6.9805223679162145
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.07142860000000001	6.9805223679162145
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.07142860000000001	6.9805223679162145
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.07142860000000001	6.9805223679162145
%609197 GLUCOCORTICOID DEFICIENCY 3; GCCD3;;FAMILIAL GLUCOCORTICOID DEFICIENCY 3; FGD3;;GLUCOCORTICOID DEFICIENCY 2, FORMERLY; GCCD2, FORMERLY	0.07142860000000001	6.9805223679162145
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.0679724	6.642757363310328
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.0679724	6.642757363310328
WILLIAMS-BEUREN SYNDROME; WBS	0.06327054	6.183257402498964
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.06257842999999999	6.115619378849354
DEAFNESS, AUTOSOMAL RECESSIVE 83	0.0625	6.107954628744835
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 38	0.0625	6.107954628744835
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 40	0.0625	6.107954628744835
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 39	0.0625	6.107954628744835
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0625	6.107954628744835
DEAFNESS, AUTOSOMAL RECESSIVE 104; DFNB104	0.0625	6.107954628744835
DEAFNESS, AUTOSOMAL RECESSIVE 62	0.0625	6.107954628744835
DEAFNESS, AUTOSOMAL RECESSIVE 49	0.0625	6.107954628744835
DEAFNESS, AUTOSOMAL RECESSIVE 44	0.0625	6.107954628744835
DEAFNESS, AUTOSOMAL RECESSIVE 45	0.0625	6.107954628744835
DEAFNESS, AUTOSOMAL RECESSIVE 71	0.0625	6.107954628744835
DEAFNESS, AUTOSOMAL RECESSIVE 85	0.0625	6.107954628744835
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.06176678000000001	6.036299036858623
HEMOCHROMATOSIS, TYPE 1	0.06176678000000001	6.036299036858623
GAPO SYNDROME	0.060340950000000004	5.896956557685772
COWDEN SYNDROME 5; CWS5	0.060340950000000004	5.896956557685772
COWDEN SYNDROME 6; CWS6	0.060340950000000004	5.896956557685772
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.06032726	5.8956186713038905
DILATED CARDIOMYOPATHY WITH ATAXIA	0.05900614	5.7665092149978525
BASAL CELL NEVUS SYNDROME	0.0588235	5.748660305663549
BIRT-HOGG-DUBÉ SYNDROME	0.0588235	5.748660305663549
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.0588235	5.748660305663549
LUMBAR SYNDROME	0.0588235	5.748660305663549
BARTSOCAS-PAPAS SYNDROME; BPS	0.0588235	5.748660305663549
PAI SYNDROME	0.0588235	5.748660305663549
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.0588235	5.748660305663549
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.05705936	5.576255712403487
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.05641948	5.513721984278027
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.05641948	5.513721984278027
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.05641948	5.513721984278027
PYGMY	0.05641948	5.513721984278027
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.056410260000000004	5.512820938811195
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.05632164	5.504160347784005
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	5.429297346763145
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.055555600000000004	5.429297346763145
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	5.429297346763145
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	5.429297346763145
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	5.429297346763145
OBESITY DUE TO SIM1 DEFICIENCY	0.055555600000000004	5.429297346763145
ESTROGEN RESISTANCE SYNDROME	0.055555600000000004	5.429297346763145
HYPERLIPOPROTEINEMIA, TYPE IV	0.055555600000000004	5.429297346763145
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	5.429297346763145
HEMOCHROMATOSIS, TYPE 4; HFE4	0.055555600000000004	5.429297346763145
HYPERTRIGLYCERIDEMIA, FAMILIAL	0.055555600000000004	5.429297346763145
ANIRIDIA	0.055555600000000004	5.429297346763145
X-LINKED SIDEROBLASTIC ANEMIA	0.055555600000000004	5.429297346763145
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.055555600000000004	5.429297346763145
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.055555600000000004	5.429297346763145
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	5.429297346763145
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.055555600000000004	5.429297346763145
HYPOGONADISM, MALE, WITH MENTAL RETARDATION AND SKELETAL ANOMALIES	0.055555600000000004	5.429297346763145
ESTROGEN RESISTANCE; ESTRR	0.055555600000000004	5.429297346763145
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.055555600000000004	5.429297346763145
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	5.429297346763145
FLYNN-AIRD SYNDROME	0.0555139	5.425222119434847
ESOPHAGEAL ATRESIA	0.055207490000000005	5.3952775053901485
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.05369004	5.246981253367926
BIEMOND SYNDROME II	0.0526316	5.143542797411947
MYASTHENIA GRAVIS; MG	0.0526316	5.143542797411947
CUTIS VERTICIS GYRATA, THYROID APLASIA, AND MENTAL RETARDATION	0.0526316	5.143542797411947
THIOUREA TASTINGPHENYLTHIOCARBAMIDE TASTING, INCLUDED	0.0526316	5.143542797411947
274210 THYMIC APLASIA WITH FETAL DEATH	0.0526316	5.143542797411947
46,XY DISORDER OF SEX DEVELOPMENT DUE TO 5-ALPHA-REDUCTASE 2 DEFICIENCY	0.0526316	5.143542797411947
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.0526316	5.143542797411947
ECTODERMAL DYSPLASIA WITH ADRENAL CYST	0.0526316	5.143542797411947
SCALP-EAR-NIPPLE SYNDROME; SENS	0.0526316	5.143542797411947
STEINERT MYOTONIC DYSTROPHY	0.0526316	5.143542797411947
MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 1	0.0526316	5.143542797411947
TIETZ SYNDROME	0.0520833	5.089958933044894
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.05150376	5.03332206863621
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.05030028	4.915709248850581
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.050079250000000006	4.894108589465118
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.05	4.886363702995869
FOIX-CHAVANY-MARIE SYNDROME	0.05	4.886363702995869
HYPOPLASTIC LEFT HEART SYNDROME	0.05	4.886363702995869
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.05	4.886363702995869
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.05	4.886363702995869
PENILE AGENESIS	0.05	4.886363702995869
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.05	4.886363702995869
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.05	4.886363702995869
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.05	4.886363702995869
FEMORAL-FACIAL SYNDROME	0.05	4.886363702995869
CAUDAL REGRESSION SEQUENCE	0.05	4.886363702995869
SYMBRACHYDACTYLY OF HANDS AND FEET	0.05	4.886363702995869
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.05	4.886363702995869
GITELMAN SYNDROME	0.05	4.886363702995869
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.05	4.886363702995869
DIABETES MELLITUS, TRANSIENT NEONATAL, 3	0.05	4.886363702995869
ULBRIGHT-HODES SYNDROME	0.05	4.886363702995869
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13	0.05	4.886363702995869
MICROFORM HOLOPROSENCEPHALY	0.05	4.886363702995869
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.05	4.886363702995869
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.05	4.886363702995869
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.04919466	4.807660020104454
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.047744360000000007	4.665926154535357
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.04774436	4.665926154535356
BRANCHIOGENIC DEAFNESS SYNDROME	0.04624060000000001	4.518967788895015
BRANCHIOOTORENAL SYNDROME 1	0.04624060000000001	4.518967788895015
LEPRECHAUNISM	0.04607101	4.502394220487194
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.04431078	4.3303717408687055
DEAFNESS, AUTOSOMAL DOMINANT 20	0.0440891	4.308707558755103
ABLEPHARON-MACROSTOMIA SYNDROME	0.043200840000000004	4.2219003302986415
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.04291218	4.193690375368505
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.042380970000000004	4.141776670115137
SHPRINTZEN OMPHALOCELE SYNDROME	0.04215154	4.11935510162757
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.042124560000000005	4.1167184197734334
CHARGE SYNDROME	0.042124560000000005	4.1167184197734334
FOCAL DERMAL HYPOPLASIA; FDH	0.042124560000000005	4.1167184197734334
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.04115122	4.021596554839953
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.040453640000000006	3.953423963001236
FETAL HYDANTOIN SYNDROME	0.040453640000000006	3.953423963001236
RAINE SYNDROME	0.040453640000000006	3.953423963001236
BECKWITH-WIEDEMANN SYNDROME	0.03922214	3.8330728249964476
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.03892477	3.8040116655092495
ATYPICAL RETT SYNDROME	0.03851489	3.763955210417571
LIP, HAMARTOMATOUS	0.0384615	3.7587375512555123
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	3.7587375512555123
BAZEX SYNDROME; BZX	0.0384615	3.7587375512555123
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	3.7587375512555123
JUVENILE ABSENCE EPILEPSY	0.0384615	3.7587375512555123
JUVENILE MYOCLONIC EPILEPSY	0.0384615	3.7587375512555123
CYCLIC NEUTROPENIA	0.0384615	3.7587375512555123
LIP, MEDIAN NODULE OF UPPER	0.0384615	3.7587375512555123
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0384615	3.7587375512555123
ACROCEPHALOPOLYDACTYLY	0.0384615	3.7587375512555123
MAL DE MELEDA	0.0384615	3.7587375512555123
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	3.7587375512555123
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	3.7587375512555123
BLEPHAROCHALASIS AND DOUBLE LIP	0.0384615	3.7587375512555123
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	3.7587375512555123
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0384615	3.7587375512555123
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	3.7587375512555123
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	3.7587375512555123
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	3.7587375512555123
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	3.7587375512555123
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.03817284	3.730527596325376
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.03791667	3.7054928005294467
WILDERVANCK SYNDROME	0.03766026	3.680434550187744
DISTAL MONOSOMY 10Q	0.03766026	3.680434550187744
WOLFRAM-LIKE SYNDROME	0.03746118	3.660979004467895
PEROXISOME BIOGENESIS DISORDER 11B	0.03723175000000001	3.6385574359803297
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.037218060000000004	3.6372195495984485
NEURONAL CEROID LIPOFUSCINOSIS	0.03604598	3.5226753662183
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.03604598	3.5226753662183
PYRIDOXINE-DEPENDENT EPILEPSY	0.03604598	3.5226753662183
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.035714300000000004	3.4902611839581072
FIBROCHONDROGENESIS	0.035714300000000004	3.4902611839581072
NIJMEGEN BREAKAGE SYNDROME	0.035714300000000004	3.4902611839581072
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.035714300000000004	3.4902611839581072
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.035714300000000004	3.4902611839581072
OTOSCLEROSIS 4	0.035714300000000004	3.4902611839581072
GERMAN SYNDROME	0.035714300000000004	3.4902611839581072
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.035714300000000004	3.4902611839581072
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.035714300000000004	3.4902611839581072
MCCUNE-ALBRIGHT SYNDROME	0.035714300000000004	3.4902611839581072
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.035714300000000004	3.4902611839581072
ALKAPTONURIA	0.035714300000000004	3.4902611839581072
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.035714300000000004	3.4902611839581072
BENIGN SCHWANNOMA	0.035714300000000004	3.4902611839581072
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.035714300000000004	3.4902611839581072
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.035714300000000004	3.4902611839581072
INCONTINENTIA PIGMENTI	0.035714300000000004	3.4902611839581072
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.035714300000000004	3.4902611839581072
STURGE-WEBER SYNDROME	0.035714300000000004	3.4902611839581072
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.035714300000000004	3.4902611839581072
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.035714300000000004	3.4902611839581072
PAPILLARY TUMOR OF THE PINEAL REGION	0.035714300000000004	3.4902611839581072
15Q OVERGROWTH SYNDROME	0.035714300000000004	3.4902611839581072
BRANCHIOSKELETOGENITAL SYNDROME	0.035714300000000004	3.4902611839581072
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.035714300000000004	3.4902611839581072
MUCOLIPIDOSIS TYPE III	0.035714300000000004	3.4902611839581072
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.035714300000000004	3.4902611839581072
HARLEQUIN ICHTHYOSIS	0.035714300000000004	3.4902611839581072
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.035714300000000004	3.4902611839581072
CROSSED POLYSYNDACTYLY	0.035714300000000004	3.4902611839581072
WAGR SYNDROME	0.035714300000000004	3.4902611839581072
OTOFACIOCERVICAL SYNDROME 2	0.035714300000000004	3.4902611839581072
PINEOCYTOMA	0.035714300000000004	3.4902611839581072
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.03562298	3.481336729290955
ACITRETIN/ETRETINATE EMBRYOPATHY	0.03504964	3.4253057739814423
PENDRED SYNDROME	0.03503788	3.424156501238498
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.0344828	3.3699100459533184
GLYCOGEN STORAGE DISEASE 0, LIVER	0.0344828	3.3699100459533184
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.0344828	3.3699100459533184
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.0344828	3.3699100459533184
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.0344828	3.3699100459533184
MODY	0.0344828	3.3699100459533184
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.0344828	3.3699100459533184
BECKWITH-WIEDEMANN SYNDROME	0.0344828	3.3699100459533184
HYPOTONIA-CYSTINURIA SYNDROME	0.0344828	3.3699100459533184
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.0344828	3.3699100459533184
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.0344828	3.3699100459533184
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.034444470000000005	3.3661641595386023
WOLF-HIRSCHHORN SYNDROME	0.03377555	3.300792431374442
YOU-HOOVER-FONG SYNDROME; YHFS	0.03377555	3.300792431374442
SANDHOFF DISEASE	0.03377555	3.300792431374442
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.03377555	3.300792431374442
MERRF	0.03376186	3.2994545449925616
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.03376186	3.2994545449925616
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.03376186	3.2994545449925616
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.033199679999999995	3.2445142260615567
ALKAPTONURIA	0.033199679999999995	3.2445142260615567
AREDYLD	0.033199679999999995	3.2445142260615567
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.03310184	3.234952589567535
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0322581	3.1524961793522204
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.0322581	3.1524961793522204
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.0322581	3.1524961793522204
HSD10 DISEASE, ATYPICAL TYPE	0.0322581	3.1524961793522204
OXOGLUTARIC ACIDURIA	0.0322581	3.1524961793522204
ISOLATED CEREBELLAR AGENESIS	0.0322581	3.1524961793522204
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.0322581	3.1524961793522204
DIENCEPHALIC SYNDROME	0.0322581	3.1524961793522204
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.0322581	3.1524961793522204
LESCH-NYHAN SYNDROME	0.0322581	3.1524961793522204
GRISCELLI SYNDROME TYPE 1	0.0322581	3.1524961793522204
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.0322581	3.1524961793522204
LEIGH SYNDROME	0.0322581	3.1524961793522204
HUNTINGTON DISEASE	0.0322581	3.1524961793522204
ISOTRETINOIN-LIKE SYNDROME	0.0313596	3.064688223609385
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.03125	3.0539773143724176
PERRAULT SYNDROME 3	0.03125	3.0539773143724176
USHER SYNDROME, TYPE IF	0.03125	3.0539773143724176
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.03125	3.0539773143724176
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.03125	3.0539773143724176
WAARDENBURG SYNDROME, TYPE 2D; WS2D	0.03125	3.0539773143724176
HYDROXYKYNURENINURIA	0.03125	3.0539773143724176
RETINITIS PUNCTATA ALBESCENS	0.03125	3.0539773143724176
DEAFNESS, AUTOSOMAL RECESSIVE 63	0.03125	3.0539773143724176
JERVELL AND LANGE-NIELSEN SYNDROME 2	0.03125	3.0539773143724176
USHER SYNDROME, TYPE IE; USH1E	0.03125	3.0539773143724176
%226500 EPIDERMOLYSIS BULLOSA DYSTROPHICA NEUROTROPHICA;;EPIDERMOLYSIS BULLOSA WITH CONGENITAL DEAFNESS;;EPIDERMOLYSIS BULLOSA PROGRESSIVA, RECESSIVE; EBR3	0.03125	3.0539773143724176
USHER SYNDROME, TYPE IIA	0.03125	3.0539773143724176
DEAFNESS-OLIGODONTIA SYNDROME	0.03125	3.0539773143724176
USHER SYNDROME, TYPE IC	0.03125	3.0539773143724176
DEAFNESS, X-LINKED 3	0.03125	3.0539773143724176
WAARDENBURG SYNDROME, TYPE 1; WS1	0.03125	3.0539773143724176
WAARDENBURG SYNDROME TYPE 1	0.03125	3.0539773143724176
DEAFNESS, AUTOSOMAL RECESSIVE 109; DFNB109	0.03125	3.0539773143724176
JERVELL AND LANGE-NIELSEN SYNDROME 1	0.03125	3.0539773143724176
USHER SYNDROME, TYPE IIC	0.03125	3.0539773143724176
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.03125	3.0539773143724176
DEAFNESS, AUTOSOMAL RECESSIVE 108; DFNB108	0.03125	3.0539773143724176
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.030915559999999998	3.021293404835819
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.02946698	2.879727630178104
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.02946698	2.879727630178104
OTOONYCHOPERONEAL SYNDROME	0.0294118	2.8743350391954774
FRYNS MICROPHTHALMIA SYNDROME	0.0294118	2.8743350391954774
EAR FOLDING	0.0294118	2.8743350391954774
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.0294118	2.8743350391954774
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.0294118	2.8743350391954774
EAR WAX, WET/DRY	0.0294118	2.8743350391954774
OSSIFIED EAR CARTILAGES	0.0294118	2.8743350391954774
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.0294118	2.8743350391954774
OSTEOMA OF MIDDLE EAR	0.0294118	2.8743350391954774
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.0294118	2.8743350391954774
BLAU SYNDROME	0.0294118	2.8743350391954774
DARWINIAN TUBERCLE OF PINNA	0.0294118	2.8743350391954774
EAR MALFORMATION	0.0294118	2.8743350391954774
VELOCARDIOFACIAL SYNDROME	0.0294118	2.8743350391954774
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.0294118	2.8743350391954774
MUSICAL PERFECT PITCH	0.0294118	2.8743350391954774
DARWINIAN POINT OF PINNA	0.0294118	2.8743350391954774
HAIRY EARS, Y-LINKED	0.0294118	2.8743350391954774
EXCHONDROSIS OF PINNA, POSTERIOR	0.0294118	2.8743350391954774
EAR WITHOUT HELIX	0.0294118	2.8743350391954774
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.0294118	2.8743350391954774
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.0294118	2.8743350391954774
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.0294118	2.8743350391954774
ROSSELLI-GULIENETTI SYNDROME	0.0294118	2.8743350391954774
EAR ANTITRAGUS, TAG AT BASE OF	0.0294118	2.8743350391954774
WAARDENBURG SYNDROME, TYPE IIB	0.02928156	2.8616070390219144
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.028352500000000003	2.7708125377838075
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	2.7146486733815727
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	2.7146486733815727
15Q13.3 MICRODELETION SYNDROME	0.027777800000000002	2.7146486733815727
DWARFISM, LEVI TYPE	0.027777800000000002	2.7146486733815727
DIMPLES, FACIAL	0.027777800000000002	2.7146486733815727
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	2.7146486733815727
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	2.7146486733815727
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	2.7146486733815727
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.027777800000000002	2.7146486733815727
CLEFT CHIN	0.027777800000000002	2.7146486733815727
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	2.7146486733815727
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	2.7146486733815727
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	2.7146486733815727
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.027777800000000002	2.7146486733815727
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	2.7146486733815727
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	2.7146486733815727
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	2.7146486733815727
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	2.7146486733815727
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	2.7146486733815727
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	2.7146486733815727
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	2.7146486733815727
CYANIDE, INABILITY TO SMELL	0.027777800000000002	2.7146486733815727
MENKES DISEASE	0.027777800000000002	2.7146486733815727
OROFACIAL CLEFT 3	0.027777800000000002	2.7146486733815727
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.027777800000000002	2.7146486733815727
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	2.7146486733815727
NASAL BONES, ABSENCE OF	0.027777800000000002	2.7146486733815727
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	2.7146486733815727
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	2.7146486733815727
CHROMOSOME 17Q12 DELETION SYNDROME	0.02724356	2.662438854487802
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.02704448	2.642983308767954
DISTAL TRISOMY 17Q	0.02557264	2.499144397715605
DEAFNESS, AUTOSOMAL DOMINANT 41; DFNA41	0.02477325	2.4210221921048483
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.02475956	2.419684305722968
221745 DEAFNESS, SENSORINEURAL, AUTOSOMAL-MITOCHONDRIAL TYPE	0.02475956	2.419684305722968
DEAFNESS, AUTOSOMAL DOMINANT 50	0.02475956	2.419684305722968
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.02475956	2.419684305722968
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.02475956	2.419684305722968
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.02462118	2.406160805538556
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.024523339999999998	2.396599169044534
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.0232558	2.2727259400826263
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 4	0.0232558	2.2727259400826263
FLYNN-AIRD SYNDROME	0.0232558	2.2727259400826263
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.0232558	2.2727259400826263
FIBROMATOSIS, GINGIVAL, WITH PROGRESSIVE DEAFNESS	0.0232558	2.2727259400826263
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.0232558	2.2727259400826263
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0232558	2.2727259400826263
DEAFNESS, AUTOSOMAL DOMINANT 70	0.0232558	2.2727259400826263
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.0232558	2.2727259400826263
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.0232558	2.2727259400826263
ALSTRÖM SYNDROME	0.0232558	2.2727259400826263
DEAFNESS-HYPOGONADISM SYNDROME	0.0232558	2.2727259400826263
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.0232558	2.2727259400826263
DEAFNESS, AUTOSOMAL RECESSIVE 111; DFNB111	0.0232558	2.2727259400826263
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 5	0.0232558	2.2727259400826263
CINCA SYNDROME; CINCA	0.0232558	2.2727259400826263
DEAFNESS, X-LINKED 2	0.0232558	2.2727259400826263
MUCKLE-WELLS SYNDROME	0.0232558	2.2727259400826263
USHER SYNDROME, TYPE IV; USH4	0.0232558	2.2727259400826263
ALSTROM SYNDROME; ALMS	0.0232558	2.2727259400826263
DEAFNESS, AUTOSOMAL DOMINANT 22; DFNA22	0.0232558	2.2727259400826263
DEAFNESS, AUTOSOMAL RECESSIVE 30; DFNB30	0.0232558	2.2727259400826263
OCULOPHARYNGODISTAL MYOPATHY	0.0232558	2.2727259400826263
TOWNES-BROCKS SYNDROME	0.02319335	2.2666228718175847
EMANUEL SYNDROME	0.02224189	2.1736392796405357
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02102928	2.055134209842739
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02102928	2.055134209842739
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02102928	2.055134209842739
GRANULOMAS, CONGENITAL CEREBRAL	0.02102928	2.055134209842739
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02102928	2.055134209842739
ENDOCARDIAL FIBROELASTOSIS	0.02093144	2.045572573348717
DE BARSY SYNDROME	0.0208333	2.0359816186724764
WOODHOUSE-SAKATI SYNDROME	0.0208333	2.0359816186724764
XQ21 MICRODELETION SYNDROME	0.0208333	2.0359816186724764
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.0208333	2.0359816186724764
DEAFNESS, AUTOSOMAL RECESSIVE 101; DFNB101	0.0208333	2.0359816186724764
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.0208333	2.0359816186724764
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.0208333	2.0359816186724764
DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY	0.0208333	2.0359816186724764
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.0208333	2.0359816186724764
DEAFNESS, AUTOSOMAL RECESSIVE 37; DFNB37	0.0208333	2.0359816186724764
N SYNDROME	0.0208333	2.0359816186724764
SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND	0.0208333	2.0359816186724764
DEAFNESS, AUTOSOMAL RECESSIVE 77; DFNB77	0.0208333	2.0359816186724764
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.0208333	2.0359816186724764
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.0208333	2.0359816186724764
MEDULLOBLASTOMA	0.0208333	2.0359816186724764
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.0208333	2.0359816186724764
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.0208333	2.0359816186724764
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.0208333	2.0359816186724764
DEAFNESS, AUTOSOMAL RECESSIVE 94; DFNB94	0.0208333	2.0359816186724764
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.0208333	2.0359816186724764
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.0208333	2.0359816186724764
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.0208333	2.0359816186724764
DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1	0.0208333	2.0359816186724764
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.0208333	2.0359816186724764
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 11	0.0208333	2.0359816186724764
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.01963832	1.9191994807163566
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.01875885	1.833251274998881
WILDERVANCK SYNDROME	0.01845401	1.8034600927744555
CRI-DU-CHAT SYNDROME	0.01845401	1.8034600927744555
CHARGE SYNDROME	0.01845401	1.8034600927744555
AURICULOCONDYLAR SYNDROME	0.01845401	1.8034600927744555
OTOMANDIBULAR SYNDROME	0.01844032	1.8021222063925753
BRANCHIOOTIC SYNDROME	0.01844032	1.8021222063925753
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.01844032	1.8021222063925753
DUANE RETRACTION SYNDROME	0.01844032	1.8021222063925753
CURRY-JONES SYNDROME	0.01752136	1.7123147506224738
TRIOPIA	0.01752136	1.7123147506224738
MOSAIC TRISOMY 15	0.0172414	1.6849550229766592
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	1.6849550229766592
ERYTHERMALGIA, PRIMARY	0.0172414	1.6849550229766592
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	1.6849550229766592
269800 SENILE PLAQUE FORMATION	0.0172414	1.6849550229766592
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	1.6849550229766592
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	1.6849550229766592
DIASTEMATOMYELIA	0.0172414	1.6849550229766592
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	1.6849550229766592
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	1.6849550229766592
SPASTIC PSEUDOSCLEROSIS	0.0172414	1.6849550229766592
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	1.6849550229766592
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	1.6849550229766592
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	1.6849550229766592
THUMBS, CONGENITAL CLASPED	0.0172414	1.6849550229766592
CONGENITAL TRACHEAL STENOSIS	0.0172414	1.6849550229766592
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	1.6849550229766592
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	1.6849550229766592
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	1.6849550229766592
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	1.6849550229766592
MOTION SICKNESS	0.0172414	1.6849550229766592
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	1.6849550229766592
PALMOMENTAL REFLEX	0.0172414	1.6849550229766592
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	1.6849550229766592
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	1.6849550229766592
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	1.6849550229766592
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	1.6849550229766592
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	1.6849550229766592
RHEUMATOID ARTHRITIS	0.0172414	1.6849550229766592
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	1.6849550229766592
ALCOHOL DEPENDENCE	0.0172414	1.6849550229766592
ANDROSTENONE, ABILITY TO SMELL	0.0172414	1.6849550229766592
JUMPING FRENCHMAN OF MAINE	0.0172414	1.6849550229766592
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	1.6849550229766592
CARDIAC ARRHYTHMIA	0.0172414	1.6849550229766592
SICKLE CELL ANEMIA	0.0172414	1.6849550229766592
TRANSSEXUALITY	0.0172414	1.6849550229766592
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	1.6849550229766592
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	1.6849550229766592
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	1.6849550229766592
MYOPATHY, CONGENITAL	0.0172414	1.6849550229766592
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	1.6849550229766592
CERVICAL RIB	0.0172414	1.6849550229766592
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	1.6849550229766592
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	1.6849550229766592
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	1.6849550229766592
OCULOAURICULOFRONTONASAL SYNDROME	0.01693656	1.655163840752234
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.01693656	1.655163840752234
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.01693656	1.655163840752234
16Q24.3 MICRODELETION SYNDROME	0.01678309	1.6401656360022585
COFFIN-SIRIS SYNDROME 1; CSS1	0.01678309	1.6401656360022585
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.01678309	1.6401656360022585
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.01678309	1.6401656360022585
OCULOCEREBROCUTANEOUS SYNDROME	0.01678309	1.6401656360022585
16P13.11 MICRODELETION SYNDROME	0.016769399999999997	1.6388277496203778
HAMAMY SYNDROME; HMMS	0.016769399999999997	1.6388277496203778
HOLOPROSENCEPHALY	0.01656789	1.6191347266245641
LAMBERT SYNDROME	0.015265639999999999	1.4918693839800368
PETERS PLUS SYNDROME	0.015265639999999999	1.4918693839800368
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.015265639999999999	1.4918693839800368
MACROSTOMIA-PREAURICULAR TAGS-EXTERNAL OPHTHALMOPLEGIA SYNDROME	0.015265639999999999	1.4918693839800368
TREACHER-COLLINS SYNDROME	0.015265639999999999	1.4918693839800368
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.015265639999999999	1.4918693839800368
8P INVERTED DUPLICATION/DELETION SYNDROME	0.015265639999999999	1.4918693839800368
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.015265639999999999	1.4918693839800368
LAMBERT SYNDROME	0.015265639999999999	1.4918693839800368
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.014898980000000001	1.4560367016732279
GLOMUVENOUS MALFORMATIONS	0.014898980000000001	1.4560367016732279
KERATOSIS, FAMILIAL ACTINIC	0.014898980000000001	1.4560367016732279
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.014898980000000001	1.4560367016732279
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.01483964	1.4502375652305122
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.01480114	1.4464750651792055
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.01438161	1.4054755418928482
ISOLATED COMPLEX I DEFICIENCY	0.01438161	1.4054755418928482
%608572 BURN-MCKEOWN SYNDROME	0.01431418	1.398885791802988
TRISOMY 18-LIKE SYNDROME	0.01431418	1.398885791802988
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.01421634	1.3893241553089657
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.01307693	1.2779727219723553
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.01287785	1.258517176252507
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.01287785	1.258517176252507
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.012667050000000001	1.2379162668806765
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.01265336	1.2365783804987962
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.01262855	1.2341537668293696
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.01262855	1.2341537668293696
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.01261486	1.2328158804474891
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.01261486	1.2328158804474891
SHORT SYNDROME	0.01261486	1.2328158804474891
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.01261486	1.2328158804474891
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.01261486	1.2328158804474891
BOR SYNDROME	0.012043749999999999	1.1770028569591298
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.012043749999999999	1.1770028569591298
CAT-EYE SYNDROME	0.012043749999999999	1.1770028569591298
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.012043749999999999	1.1770028569591298
ACROCALLOSAL SYNDROME; ACLS	0.012043749999999999	1.1770028569591298
MICROPHTHALMIA, LENZ TYPE	0.012043749999999999	1.1770028569591298
14Q22Q23 MICRODELETION SYNDROME	0.012043749999999999	1.1770028569591298
TRISOMY 13	0.012030059999999999	1.1756649705772493
KABUKI SYNDROME	0.012030059999999999	1.1756649705772493
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.012030059999999999	1.1756649705772493
LOWE-KOHN-COHEN SYNDROME	0.012030059999999999	1.1756649705772493
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.012030059999999999	1.1756649705772493
TOWNES-BROCKS SYNDROME 1; TBS1	0.012030059999999999	1.1756649705772493
COHEN SYNDROME	0.012030059999999999	1.1756649705772493
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.012030059999999999	1.1756649705772493
GROWTH HORMONE INSENSITIVITY SYNDROME	0.011874160000000002	1.1604292885513086
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.011874160000000002	1.1604292885513086
CHROMOSOME 10Q26 DELETION SYNDROME	0.0117019	1.143594788321747
SMITH-KINGSMORE SYNDROME; SKS	0.011406010000000001	1.1146782652001581
SIMPSON-GOLABI-BEHMEL SYNDROME	0.011406010000000001	1.1146782652001581
MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS	0.011149599999999999	1.0896200148584545
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.011149599999999999	1.0896200148584545
MOSAIC TRISOMY 1	0.011149599999999999	1.0896200148584545
ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL	0.0111111	1.0858575148071479
LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	0.0111111	1.0858575148071479
DERMAL RIDGES, PATTERNLESS	0.0111111	1.0858575148071479
GM1 GANGLIOSIDOSIS	0.0111111	1.0858575148071479
LICHEN PLANUS, FAMILIAL	0.0111111	1.0858575148071479
NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES	0.0111111	1.0858575148071479
DERMATOSIS PAPULOSA NIGRA	0.0111111	1.0858575148071479
LENTIGINES	0.0111111	1.0858575148071479
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.0111111	1.0858575148071479
SIMOSA CRANIOFACIAL SYNDROME	0.0111111	1.0858575148071479
CIRCUMVALLATE PLACENTA SYNDROME	0.0111111	1.0858575148071479
ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	0.0111111	1.0858575148071479
PAPILLOMATOSIS, FLORID, OF NIPPLE	0.0111111	1.0858575148071479
LIPOMATOSIS, FAMILIAL BENIGN CERVICAL	0.0111111	1.0858575148071479
SAY SYNDROME	0.0111111	1.0858575148071479
COMEDONES, FAMILIAL DYSKERATOTIC	0.0111111	1.0858575148071479
MUCOPOLYSACCHARIDOSIS TYPE IX	0.0111111	1.0858575148071479
MARFANOID HYPERMOBILITY SYNDROME	0.0111111	1.0858575148071479
ACROMIAL DIMPLES	0.0111111	1.0858575148071479
SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE	0.0111111	1.0858575148071479
FASCIAL DYSTROPHY, CONGENITAL	0.0111111	1.0858575148071479
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA	0.0111111	1.0858575148071479
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0111111	1.0858575148071479
LATERAL MENINGOCELE SYNDROME	0.0111111	1.0858575148071479
PATELLA APLASIA-HYPOPLASIA	0.0111111	1.0858575148071479
PARANA HARD-SKIN SYNDROME	0.0111111	1.0858575148071479
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.0111111	1.0858575148071479
AMYLOIDOSIS, CUTANEOUS BULLOUS	0.0111111	1.0858575148071479
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.0111111	1.0858575148071479
FUTCHER LINE	0.0111111	1.0858575148071479
CAMOS SYNDROME	0.0111111	1.0858575148071479
CALLOSITIES, HEREDITARY PAINFUL	0.0111111	1.0858575148071479
SCALP-EAR-NIPPLE SYNDROME	0.0111111	1.0858575148071479
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.0111111	1.0858575148071479
PERIODONTITIS, AGGRESSIVE, 1	0.0111111	1.0858575148071479
PSEUDOATROPHODERMA COLLI	0.0111111	1.0858575148071479
PRENATAL BOWING	0.0111111	1.0858575148071479
131600 EPIDERMOID CYSTS	0.0111111	1.0858575148071479
CAROTENEMIA, FAMILIAL	0.0111111	1.0858575148071479
SPINOCEREBELLAR ATAXIA 34; SCA34	0.0111111	1.0858575148071479
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.0111111	1.0858575148071479
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.0111111	1.0858575148071479
TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL	0.0111111	1.0858575148071479
URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1	0.0111111	1.0858575148071479
TYROSINE TRANSAMINASE DEFICIENCY	0.0111111	1.0858575148071479
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1; HFTC1	0.0111111	1.0858575148071479
KYRLE DISEASE	0.0111111	1.0858575148071479
PILONIDAL SINUS	0.0111111	1.0858575148071479
TRICHILEMMAL CYST 1	0.0111111	1.0858575148071479
EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL	0.0111111	1.0858575148071479
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0111111	1.0858575148071479
METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA	0.0111111	1.0858575148071479
HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS	0.0111111	1.0858575148071479
PIGMENTED PURPURIC ERUPTION	0.0111111	1.0858575148071479
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.0111111	1.0858575148071479
HYPOPLASMINOGENEMIA	0.0111111	1.0858575148071479
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.0111111	1.0858575148071479
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.0111111	1.0858575148071479
INSECT STINGS, HYPERSENSITIVITY TO	0.0111111	1.0858575148071479
PYCNODYSOSTOSIS	0.0111111	1.0858575148071479
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME;;ECP SYNDROME	0.0111111	1.0858575148071479
SYRINGOMAS, MULTIPLE	0.0111111	1.0858575148071479
POLYVALVULAR HEART DISEASE SYNDROME	0.0111111	1.0858575148071479
CAT-EYE SYNDROME (TYPE I)	0.010526299999999999	1.028706604936908
EMANUEL SYNDROME	0.010526299999999999	1.028706604936908
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.010526299999999999	1.028706604936908
MICROPHTHALMIA, SYNDROMIC 4	0.010526299999999999	1.028706604936908
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.010526299999999999	1.028706604936908
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.010526299999999999	1.028706604936908
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.010526299999999999	1.028706604936908
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.010526299999999999	1.028706604936908
PREAURICULAR TAG, ISOLATED, AUTOSOMAL DOMINANT, 1	0.010526299999999999	1.028706604936908
CRANIOTELENCEPHALIC DYSPLASIA	0.010526299999999999	1.028706604936908
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.010526299999999999	1.028706604936908
PROXIMAL SPINAL MUSCULAR ATROPHY	0.010526299999999999	1.028706604936908
MONOSOMY 5P	0.010526299999999999	1.028706604936908
3C SYNDROME	0.010526299999999999	1.028706604936908
KAPUR-TORIELLO SYNDROME	0.010526299999999999	1.028706604936908
FRONTONASAL DYSPLASIA	0.010526299999999999	1.028706604936908
KAPUR-TORIELLO SYNDROME	0.010526299999999999	1.028706604936908
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.010526299999999999	1.028706604936908
DEXTROCARDIA	0.010526299999999999	1.028706604936908
TRISOMY 8P	0.010526299999999999	1.028706604936908
TRISOMY 18P	0.010526299999999999	1.028706604936908
FRONTOFACIONASAL DYSPLASIA	0.010526299999999999	1.028706604936908
TETRAPLOIDY	0.010526299999999999	1.028706604936908
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.010526299999999999	1.028706604936908
1Q44 MICRODELETION SYNDROME	0.010526299999999999	1.028706604936908
FRONTORHINY	0.010526299999999999	1.028706604936908
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.010526299999999999	1.028706604936908
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.010526299999999999	1.028706604936908
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.010526299999999999	1.028706604936908
FRONTONASAL DYSPLASIA 1; FND1	0.010526299999999999	1.028706604936908
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.010526299999999999	1.028706604936908
GLYCEROL KINASE DEFICIENCY; GKD	0.01035671	1.0121330365290868
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.01035671	1.0121330365290868
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.01035671	1.0121330365290868
LARON SYNDROME	0.01035671	1.0121330365290868
BARAITSER-WINTER SYNDROME 1; BRWS1	0.01003098	0.9803003315495499
MONOSOMY 18Q	0.00993314	0.9707386950555277
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.00993314	0.9707386950555277
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.00990122	0.9676192404675351
PRADER-WILLI SYNDROME	0.00990122	0.9676192404675351
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00990122	0.9676192404675351
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.008995369999999999	0.8790929892603587
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00852722	0.8333419659092086
ASPARTYLGLUCOSAMINURIA; AGU	0.00852722	0.8333419659092086
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.00842938	0.8237803294151863
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00842938	0.8237803294151863
NOONAN SYNDROME 5; NS5	0.00842938	0.8237803294151863
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.00842938	0.8237803294151863
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00842938	0.8237803294151863
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.00842938	0.8237803294151863
SSR4-CDG	0.00842938	0.8237803294151863
VERVERI-BRADY SYNDROME; VERBRAS	0.00842938	0.8237803294151863
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.00842938	0.8237803294151863
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.00842938	0.8237803294151863
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.00842938	0.8237803294151863
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00842938	0.8237803294151863
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.00842938	0.8237803294151863
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.00842938	0.8237803294151863
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.00842938	0.8237803294151863
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.00818412	0.799811738179251
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.00818412	0.799811738179251
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.00818412	0.799811738179251
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.008170430000000001	0.7984738517973707
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.008170430000000001	0.7984738517973707
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.008170430000000001	0.7984738517973707
SHEEHAN SYNDROME	0.008170430000000001	0.7984738517973707
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.008170430000000001	0.7984738517973707
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.008170430000000001	0.7984738517973707
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.008170430000000001	0.7984738517973707
CADASIL	0.008170430000000001	0.7984738517973707
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.008170430000000001	0.7984738517973707
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.008170430000000001	0.7984738517973707
WITTEVEEN-KOLK SYNDROME	0.007927710000000001	0.7747534878375476
GORDON SYNDROME	0.007927710000000001	0.7747534878375476
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.007927710000000001	0.7747534878375476
CORNELIA DE LANGE SYNDROME 3	0.007927710000000001	0.7747534878375476
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.007927710000000001	0.7747534878375476
KLEEFSTRA SYNDROME	0.007927710000000001	0.7747534878375476
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.007927710000000001	0.7747534878375476
WYBURN-MASON SYNDROME	0.007927710000000001	0.7747534878375476
15Q24 MICRODELETION SYNDROME	0.007927710000000001	0.7747534878375476
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.007927710000000001	0.7747534878375476
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.007927710000000001	0.7747534878375476
OROFACIODIGITAL SYNDROME TYPE 1	0.007927710000000001	0.7747534878375476
FEINGOLD SYNDROME 1; FGLDS1	0.007927710000000001	0.7747534878375476
ISOLATED KLIPPEL-FEIL SYNDROME	0.007927710000000001	0.7747534878375476
SCLEROSTEOSIS 2; SOST2	0.007927710000000001	0.7747534878375476
FOCAL DERMAL HYPOPLASIA	0.007927710000000001	0.7747534878375476
OROFACIODIGITAL SYNDROME I; OFD1	0.007927710000000001	0.7747534878375476
MELNICK-NEEDLES SYNDROME	0.007927710000000001	0.7747534878375476
ISOLATED PLAGIOCEPHALY	0.007927710000000001	0.7747534878375476
FANCONI ANEMIA	0.007927710000000001	0.7747534878375476
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.007927710000000001	0.7747534878375476
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.007927710000000001	0.7747534878375476
DEAFNESS-CRANIOFACIAL SYNDROME	0.007927710000000001	0.7747534878375476
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.007927710000000001	0.7747534878375476
SAETHRE-CHOTZEN SYNDROME	0.00791402	0.7734156014556673
15Q26 OVERGROWTH SYNDROME	0.00791402	0.7734156014556673
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.00791402	0.7734156014556673
CRANIOFRONTONASAL DYSPLASIA	0.00791402	0.7734156014556673
DEAFNESS-CRANIOFACIAL SYNDROME	0.00791402	0.7734156014556673
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00791402	0.7734156014556673
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.00791402	0.7734156014556673
DUANE-RADIAL RAY SYNDROME; DRRS	0.00791402	0.7734156014556673
CONGENITAL HYDROCEPHALUS	0.00791402	0.7734156014556673
APERT SYNDROME	0.00791402	0.7734156014556673
PRIMROSE SYNDROME; PRIMS	0.00772863	0.7552979421176992
BARDET-BIEDL SYNDROME 1; BBS1	0.00772863	0.7552979421176992
FRIEDREICH ATAXIA	0.00772863	0.7552979421176992
ERYTHROKERATODERMIA VARIABILIS	0.00772863	0.7552979421176992
17Q12 MICRODELETION SYNDROME	0.00772863	0.7552979421176992
DYSKERATOSIS CONGENITA	0.00772863	0.7552979421176992
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00772863	0.7552979421176992
H SYNDROME	0.00772863	0.7552979421176992
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.00772863	0.7552979421176992
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.00772863	0.7552979421176992
BETA-THALASSEMIA MAJOR	0.00772863	0.7552979421176992
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00772863	0.7552979421176992
NEUTRAL LIPID STORAGE MYOPATHY	0.00771494	0.7539600557358189
RENPENNING SYNDROME	0.00771494	0.7539600557358189
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00771494	0.7539600557358189
NORRIE DISEASE	0.00771494	0.7539600557358189
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.00771494	0.7539600557358189
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00771494	0.7539600557358189
SHORT SYNDROME	0.00771494	0.7539600557358189
RAMON SYNDROME	0.00771494	0.7539600557358189
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.00771494	0.7539600557358189
WOODHOUSE-SAKATI SYNDROME	0.00771494	0.7539600557358189
JOHANSON-BLIZZARD SYNDROME; JBS	0.00771494	0.7539600557358189
JOHANSON-BLIZZARD SYNDROME	0.00771494	0.7539600557358189
WOLFRAM SYNDROME 2; WFS2	0.00771494	0.7539600557358189
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.00771494	0.7539600557358189
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.00771494	0.7539600557358189
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.00771494	0.7539600557358189
KEARNS-SAYRE SYNDROME; KSS	0.00771494	0.7539600557358189
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.00771494	0.7539600557358189
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.00771494	0.7539600557358189
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.00771494	0.7539600557358189
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00771494	0.7539600557358189
WOLFRAM SYNDROME	0.00771494	0.7539600557358189
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00771494	0.7539600557358189
EPILEPSY-TELANGIECTASIA	0.00747792	0.7307967372381372
NEPHROSIALIDOSIS	0.00747792	0.7307967372381372
SHORT STATURE DUE TO PARTIAL GHR DEFICIENCY	0.00666667	0.6515154861570294
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.00666667	0.6515154861570294
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.00666667	0.6515154861570294
SHORT STATURE DUE TO GHSR DEFICIENCY	0.00666667	0.6515154861570294
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.00666667	0.6515154861570294
ADDISON DISEASE	0.00666667	0.6515154861570294
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00666667	0.6515154861570294
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.00666667	0.6515154861570294
CONGENITAL ISOLATED HYPERINSULINISM	0.00666667	0.6515154861570294
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.00666667	0.6515154861570294
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.00666667	0.6515154861570294
ORNITHINE TRANSCARBAMYLASE DEFICIENCY	0.00666667	0.6515154861570294
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.00666667	0.6515154861570294
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.00666667	0.6515154861570294
ORTHOSTATIC HYPOTENSION 2; ORTHYP2	0.00666667	0.6515154861570294
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.00666667	0.6515154861570294
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00666667	0.6515154861570294
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.00666667	0.6515154861570294
PROPIONIC ACIDEMIA	0.00666667	0.6515154861570294
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.00666667	0.6515154861570294
MIRAGE SYNDROME; MIRAGE	0.00666667	0.6515154861570294
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.00666667	0.6515154861570294
PROPIONIC ACIDEMIA	0.00666667	0.6515154861570294
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.00666667	0.6515154861570294
GALACTOSEMIA	0.00666667	0.6515154861570294
SHASHI-PENA SYNDROME; SHAPNS	0.00666667	0.6515154861570294
INFANTILE LIVER FAILURE SYNDROME 2	0.00666667	0.6515154861570294
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.00666667	0.6515154861570294
TENORIO SYNDROME; TNORS	0.00666667	0.6515154861570294
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00666667	0.6515154861570294
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.00666667	0.6515154861570294
HEPATOCELLULAR CARCINOMA	0.00666667	0.6515154861570294
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.00666667	0.6515154861570294
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.00666667	0.6515154861570294
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.00666667	0.6515154861570294
RIBOFLAVIN DEFICIENCY	0.00666667	0.6515154861570294
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.00666667	0.6515154861570294
MPI-CDG	0.00666667	0.6515154861570294
MENKES DISEASE	0.00666667	0.6515154861570294
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.00666667	0.6515154861570294
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.00666667	0.6515154861570294
CLASSIC GALACTOSEMIA	0.00666667	0.6515154861570294
POST-TRAUMATIC PITUITARY DEFICIENCY	0.00666667	0.6515154861570294
ACUTE ADRENAL INSUFFICIENCY	0.00666667	0.6515154861570294
PITUITARY APOPLEXY	0.00666667	0.6515154861570294
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.00666667	0.6515154861570294
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.00666667	0.6515154861570294
PITUITARY STALK INTERRUPTION SYNDROME	0.00666667	0.6515154861570294
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.00666667	0.6515154861570294
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.00666667	0.6515154861570294
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.00666667	0.6515154861570294
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.00666667	0.6515154861570294
COG8-CDG	0.00666667	0.6515154861570294
ENDOCARDIAL FIBROELASTOSIS	0.00666667	0.6515154861570294
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.00666667	0.6515154861570294
WOLCOTT-RALLISON SYNDROME	0.00666667	0.6515154861570294
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.00666667	0.6515154861570294
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.00666667	0.6515154861570294
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.00666667	0.6515154861570294
PANHYPOPITUITARISM	0.00666667	0.6515154861570294
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.00666667	0.6515154861570294
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.00666667	0.6515154861570294
GLYCOGEN STORAGE DISEASE DUE TO LIVER GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.00666667	0.6515154861570294
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00666667	0.6515154861570294
BETA-KETOTHIOLASE DEFICIENCY	0.00666667	0.6515154861570294
CONGENITAL DISORDER OF GLYCOSYLATION	0.00666667	0.6515154861570294
HISTIOCYTOID CARDIOMYOPATHY	0.00666667	0.6515154861570294
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00666667	0.6515154861570294
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.00666667	0.6515154861570294
OCULODENTODIGITAL DYSPLASIA	0.00666667	0.6515154861570294
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.00666667	0.6515154861570294
2P21 MICRODELETION SYNDROME	0.00666667	0.6515154861570294
NEONATAL HEMOCHROMATOSIS	0.00666667	0.6515154861570294
SOTOS SYNDROME	0.00666667	0.6515154861570294
GLYCOGEN STORAGE DISEASE IA	0.00666667	0.6515154861570294
TYROSINEMIA, TYPE I; TYRSN1	0.00666667	0.6515154861570294
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00666667	0.6515154861570294
PYRUVATE CARBOXYLASE DEFICIENCY	0.00666667	0.6515154861570294
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.00666667	0.6515154861570294
COSTELLO SYNDROME; CSTLO	0.00666667	0.6515154861570294
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2	0.00666667	0.6515154861570294
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.00666667	0.6515154861570294
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.00666667	0.6515154861570294
HYPOADRENOCORTICISM, FAMILIAL	0.00666667	0.6515154861570294
GLYCOGEN STORAGE DISEASE IXA	0.00666667	0.6515154861570294
HOLOPROSENCEPHALY 1; HPE1	0.00666667	0.6515154861570294
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.00666667	0.6515154861570294
GLYCOGEN STORAGE DISEASE VI	0.00666667	0.6515154861570294
MEHMO SYNDROME; MEHMO	0.00666667	0.6515154861570294
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.00666667	0.6515154861570294
GLYCOGEN STORAGE DISEASE IB	0.00666667	0.6515154861570294
GLUTARIC ACIDEMIA I; GA1	0.00666667	0.6515154861570294
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	0.00666667	0.6515154861570294
HEMOCHROMATOSIS, NEONATAL	0.00666667	0.6515154861570294
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00666667	0.6515154861570294
FRUCTOSE AND GALACTOSE INTOLERANCE	0.00666667	0.6515154861570294
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00666667	0.6515154861570294
VISCERAL STEATOSIS, CONGENITAL	0.00666667	0.6515154861570294
PITUITARY DWARFISM WITH SMALL SELLA TURCICA	0.00666667	0.6515154861570294
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.00666667	0.6515154861570294
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.00666667	0.6515154861570294
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.00666667	0.6515154861570294
NAVAJO NEUROHEPATOPATHY	0.00666667	0.6515154861570294
MAPLE SYRUP URINE DISEASE; MSUD	0.00666667	0.6515154861570294
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.00666667	0.6515154861570294
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.00666667	0.6515154861570294
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.00666667	0.6515154861570294
PHOSPHOENOLPYRUVATE CARBOXYKINASE 2, MITOCHONDRIAL	0.00666667	0.6515154861570294
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.00666667	0.6515154861570294
TIMOTHY SYNDROME; TS	0.00666667	0.6515154861570294
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.00666667	0.6515154861570294
MALAN OVERGROWTH SYNDROME	0.00641026	0.6264572358153259
WIEDEMANN-STEINER SYNDROME	0.00641026	0.6264572358153259
X-LINKED INTELLECTUAL DISABILITY, MILES-CARPENTER TYPE	0.00641026	0.6264572358153259
OCULOECTODERMAL SYNDROME; OES	0.00641026	0.6264572358153259
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00641026	0.6264572358153259
MULTIPLE SYNOSTOSES SYNDROME	0.00641026	0.6264572358153259
DUBOWITZ SYNDROME	0.00641026	0.6264572358153259
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.00641026	0.6264572358153259
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.00641026	0.6264572358153259
ZTTK SYNDROME; ZTTKS	0.00641026	0.6264572358153259
LAMB-SHAFFER SYNDROME	0.00641026	0.6264572358153259
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00641026	0.6264572358153259
3Q29 MICRODELETION SYNDROME	0.00641026	0.6264572358153259
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 3	0.00641026	0.6264572358153259
TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	0.00641026	0.6264572358153259
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00641026	0.6264572358153259
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.00641026	0.6264572358153259
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.00641026	0.6264572358153259
POLYCYSTIC KIDNEY DISEASE 2	0.00641026	0.6264572358153259
ELSAHY-WATERS SYNDROME; ESWS	0.00641026	0.6264572358153259
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.00641026	0.6264572358153259
FAMILIAL LAMBDOID SYNOSTOSIS	0.00641026	0.6264572358153259
VELO-FACIAL-SKELETAL SYNDROME	0.00641026	0.6264572358153259
GABRIELE-DE VRIES SYNDROME	0.00641026	0.6264572358153259
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.00641026	0.6264572358153259
TETRASOMY 18P	0.00641026	0.6264572358153259
CRANIOFRONTONASAL SYNDROME; CFNS	0.00641026	0.6264572358153259
SECKEL SYNDROME 1; SCKL1	0.00641026	0.6264572358153259
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00641026	0.6264572358153259
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.00641026	0.6264572358153259
GABRIELE-DE VRIES SYNDROME; GADEVS	0.00641026	0.6264572358153259
BLEPHAROCHEILODONTIC SYNDROME 2; BCDS2	0.00641026	0.6264572358153259
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00641026	0.6264572358153259
CLAPO SYNDROME	0.00641026	0.6264572358153259
TEMTAMY SYNDROME	0.00641026	0.6264572358153259
PFEIFFER SYNDROME	0.00641026	0.6264572358153259
SPINOCEREBELLAR ATAXIA TYPE 34	0.00641026	0.6264572358153259
GRANT SYNDROME	0.00641026	0.6264572358153259
ISOLATED HEMIHYPERPLASIA	0.00641026	0.6264572358153259
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.00641026	0.6264572358153259
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00641026	0.6264572358153259
PSEUDOAMINOPTERIN SYNDROME	0.00641026	0.6264572358153259
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.00641026	0.6264572358153259
LINEAR NEVUS SEBACEUS SYNDROME	0.00641026	0.6264572358153259
JACOBSEN SYNDROME	0.00641026	0.6264572358153259
JOHNSON NEUROECTODERMAL SYNDROME	0.00641026	0.6264572358153259
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.00641026	0.6264572358153259
OCULOCEREBROCUTANEOUS SYNDROME	0.00641026	0.6264572358153259
2Q32Q33 MICRODELETION SYNDROME	0.00641026	0.6264572358153259
PROTEUS SYNDROME	0.00641026	0.6264572358153259
OTOFACIOCERVICAL SYNDROME	0.00641026	0.6264572358153259
CURRY-JONES SYNDROME	0.00641026	0.6264572358153259
48,XXYY SYNDROME	0.00641026	0.6264572358153259
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00641026	0.6264572358153259
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.00641026	0.6264572358153259
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.00641026	0.6264572358153259
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.00641026	0.6264572358153259
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.00641026	0.6264572358153259
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.00641026	0.6264572358153259
HEMIFACIAL HYPERPLASIA	0.00641026	0.6264572358153259
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00641026	0.6264572358153259
CRANIOFACIAL DYSSYNOSTOSIS	0.00641026	0.6264572358153259
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00641026	0.6264572358153259
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00641026	0.6264572358153259
PROGRESSIVE HEMIFACIAL ATROPHY	0.00641026	0.6264572358153259
BENCZE SYNDROME	0.00641026	0.6264572358153259
CAFFEY DISEASE	0.00641026	0.6264572358153259
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00641026	0.6264572358153259
PHAKOMATOSIS PIGMENTOVASCULARIS	0.00641026	0.6264572358153259
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.00641026	0.6264572358153259
2Q31.1 MICRODELETION SYNDROME	0.00641026	0.6264572358153259
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.00641026	0.6264572358153259
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.00641026	0.6264572358153259
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00641026	0.6264572358153259
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.00641026	0.6264572358153259
48,XXXY SYNDROME	0.00641026	0.6264572358153259
TORTICOLLIS	0.00641026	0.6264572358153259
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00641026	0.6264572358153259
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.00641026	0.6264572358153259
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.00625679	0.6114590310653504
COFFIN-SIRIS SYNDROME	0.00625679	0.6114590310653504
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00625679	0.6114590310653504
DUPLICATION OF THE PITUITARY GLAND	0.00625679	0.6114590310653504
TRISOMY 17P	0.00625679	0.6114590310653504
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.00625679	0.6114590310653504
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.00625679	0.6114590310653504
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.00625679	0.6114590310653504
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.00625679	0.6114590310653504
COFFIN-SIRIS SYNDROME 4; CSS4	0.00625679	0.6114590310653504
COFFIN-SIRIS SYNDROME 3; CSS3	0.00625679	0.6114590310653504
BARAITSER-WINTER SYNDROME 2; BRWS2	0.00625679	0.6114590310653504
NAGER SYNDROME	0.00625679	0.6114590310653504
COFFIN-SIRIS SYNDROME 7; CSS7	0.00625679	0.6114590310653504
BARBER-SAY SYNDROME	0.00625679	0.6114590310653504
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00625679	0.6114590310653504
19Q13.11 MICRODELETION SYNDROME	0.00625679	0.6114590310653504
BARBER-SAY SYNDROME; BBRSAY	0.00625679	0.6114590310653504
ABLEPHARON MACROSTOMIA SYNDROME	0.00625679	0.6114590310653504
17P11.2 MICRODUPLICATION SYNDROME	0.00625679	0.6114590310653504
DUBOWITZ SYNDROME	0.00625679	0.6114590310653504
WARSAW BREAKAGE SYNDROME; WABS	0.00625679	0.6114590310653504
MORQUIO SYNDROME A	0.00625679	0.6114590310653504
POTOCKI-LUPSKI SYNDROME	0.00625679	0.6114590310653504
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.0062431	0.6101211446834701
BILATERAL POLYMICROGYRIA	0.0062431	0.6101211446834701
COFFIN-LOWRY SYNDROME	0.0062431	0.6101211446834701
SMITH-LEMLI-OPITZ SYNDROME	0.0062431	0.6101211446834701
FG SYNDROME TYPE 1	0.0062431	0.6101211446834701
SCHEIE SYNDROME	0.0062431	0.6101211446834701
ZIMMERMANN-LABAND SYNDROME	0.0062431	0.6101211446834701
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.0062431	0.6101211446834701
FOUNTAIN SYNDROME	0.0062431	0.6101211446834701
WILLIAMS SYNDROME	0.0062431	0.6101211446834701
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.0062431	0.6101211446834701
PETTIGREW SYNDROME	0.0062431	0.6101211446834701
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.0062431	0.6101211446834701
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.0062431	0.6101211446834701
BARDET-BIEDL SYNDROME 2	0.00621118	0.6070016900954777
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.00621118	0.6070016900954777
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.00621118	0.6070016900954777
HYPERLIPOPROTEINEMIA, TYPE V	0.00621118	0.6070016900954777
NEUROTROPHIC KERATOPATHY	0.00621118	0.6070016900954777
CUSHING DISEASE	0.00621118	0.6070016900954777
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.00621118	0.6070016900954777
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00621118	0.6070016900954777
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.00621118	0.6070016900954777
AFRICAN IRON OVERLOAD	0.00621118	0.6070016900954777
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.00621118	0.6070016900954777
PERIPARTUM CARDIOMYOPATHY	0.00621118	0.6070016900954777
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.00621118	0.6070016900954777
SOMATOSTATINOMA	0.00621118	0.6070016900954777
FAMILIAL PANCREATIC CARCINOMA	0.00621118	0.6070016900954777
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.00621118	0.6070016900954777
144800 HYPEROSTOSIS FRONTALIS INTERNA;;MORGAGNI-STEWART-MOREL SYNDROME	0.00621118	0.6070016900954777
VIPOMA	0.00621118	0.6070016900954777
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.00621118	0.6070016900954777
AICARDI-GOUTIÈRES SYNDROME	0.00621118	0.6070016900954777
GLUCAGONOMA	0.00621118	0.6070016900954777
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.00621118	0.6070016900954777
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11	0.00621118	0.6070016900954777
ADRENOCORTICAL CARCINOMA	0.00621118	0.6070016900954777
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 14; MODY14	0.00621118	0.6070016900954777
SPLENOPORTAL VASCULAR ANOMALIES	0.00621118	0.6070016900954777
FAMILIAL PARTIAL LIPODYSTROPHY, KÖBBERLING TYPE	0.00621118	0.6070016900954777
DYSTROPHIA MYOTONICA 2	0.00621118	0.6070016900954777
CUSHING SYNDROME	0.00621118	0.6070016900954777
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00621118	0.6070016900954777
OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE; OPLL	0.00621118	0.6070016900954777
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.00621118	0.6070016900954777
CRANIAL NERVES, RECURRENT PARESIS OF	0.00621118	0.6070016900954777
12Q14 MICRODELETION SYNDROME	0.00621118	0.6070016900954777
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.00621118	0.6070016900954777
DIABETES MELLITUS, INSULIN-DEPENDENT, 2	0.00621118	0.6070016900954777
DIABETES MELLITUS, INSULIN-DEPENDENT, 6	0.00621118	0.6070016900954777
ACROMEGALY	0.00621118	0.6070016900954777
SOMATOMAMMOTROPINOMA	0.00621118	0.6070016900954777
MEHMO SYNDROME	0.00621118	0.6070016900954777
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.00621118	0.6070016900954777
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00621118	0.6070016900954777
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00621118	0.6070016900954777
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.00621118	0.6070016900954777
%601666 DIABETES MELLITUS, INSULIN-DEPENDENT, 15; IDDM15;;INSULIN-DEPENDENT DIABETES MELLITUS 15	0.00621118	0.6070016900954777
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.00621118	0.6070016900954777
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.00621118	0.6070016900954777
POLAND SYNDROME	0.00621118	0.6070016900954777
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00621118	0.6070016900954777
WERNER SYNDROME; WRN	0.00621118	0.6070016900954777
HEMOCHROMATOSIS TYPE 2	0.00621118	0.6070016900954777
POEMS SYNDROME	0.00621118	0.6070016900954777
RCAD (RENAL CYSTS AND DIABETES)	0.00621118	0.6070016900954777
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.00621118	0.6070016900954777
MT-ATP6-RELATED MITOCHONDRIAL SPASTIC PARAPLEGIA	0.00621118	0.6070016900954777
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.00621118	0.6070016900954777
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.00621118	0.6070016900954777
DIABETES MELLITUS, INSULIN-DEPENDENT, 10	0.00621118	0.6070016900954777
PREAXIAL HALLUCAL POLYDACTYLY	0.00621118	0.6070016900954777
INSULINOMATOSIS AND DIABETES MELLITUS; INSDM	0.00621118	0.6070016900954777
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.00621118	0.6070016900954777
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.00621118	0.6070016900954777
DIABETES MELLITUS, KETOSIS-PRONE; KPD	0.00621118	0.6070016900954777
ALEXANDER DISEASE	0.00621118	0.6070016900954777
STIFF-PERSON SYNDROME; SPS	0.00621118	0.6070016900954777
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.00621118	0.6070016900954777
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00621118	0.6070016900954777
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.00621118	0.6070016900954777
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.00621118	0.6070016900954777
BETA-THALASSEMIA INTERMEDIA	0.00621118	0.6070016900954777
ACTH-INDEPENDENT CUSHING SYNDROME	0.00621118	0.6070016900954777
BULLOUS PEMPHIGOID	0.00621118	0.6070016900954777
ACERULOPLASMINEMIA	0.00621118	0.6070016900954777
ACERULOPLASMINEMIA	0.00621118	0.6070016900954777
EPIDERMOLYSIS BULLOSA ACQUISITA	0.00621118	0.6070016900954777
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.00621118	0.6070016900954777
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.00621118	0.6070016900954777
DYSBETALIPOPROTEINEMIA	0.00621118	0.6070016900954777
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.00621118	0.6070016900954777
ACTH-DEPENDENT CUSHING SYNDROME	0.00621118	0.6070016900954777
BARDET-BIEDL SYNDROME 6; BBS6	0.00621118	0.6070016900954777
HEREDITARY CHRONIC PANCREATITIS	0.00621118	0.6070016900954777
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.00621118	0.6070016900954777
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00621118	0.6070016900954777
ATAXIA WITH VITAMIN E DEFICIENCY	0.00621118	0.6070016900954777
MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS	0.00621118	0.6070016900954777
167755 PANCREAS, DORSAL, AGENESIS OF	0.00621118	0.6070016900954777
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.00621118	0.6070016900954777
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.00621118	0.6070016900954777
PAROXYSMAL HEMICRANIA	0.00621118	0.6070016900954777
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.00621118	0.6070016900954777
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.00621118	0.6070016900954777
PANCREATITIS, HEREDITARY	0.00621118	0.6070016900954777
GOOD SYNDROME	0.00621118	0.6070016900954777
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.00621118	0.6070016900954777
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.00621118	0.6070016900954777
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.0053053300000000005	0.5184754388883015
46,XX GONADAL DYSGENESIS	0.0053053300000000005	0.5184754388883015
CONE-ROD DYSTROPHY 1; CORD1	0.0053053300000000005	0.5184754388883015
XYLOSIDASE DEFICIENCY	0.0053053300000000005	0.5184754388883015
FETAL IODINE DEFICIENCY DISORDER	0.0053053300000000005	0.5184754388883015
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.00529164	0.5171375525064211
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.00529164	0.5171375525064211
NEONATAL ADRENOLEUKODYSTROPHY	0.00529164	0.5171375525064211
REFSUM DISEASE	0.00529164	0.5171375525064211
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.00529164	0.5171375525064211
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00529164	0.5171375525064211
HYPERLEUCINE-ISOLEUCINEMIA	0.00529164	0.5171375525064211
PITT-HOPKINS-LIKE SYNDROME	0.00520749	0.5089138023942791
XP22.13P22.2 DUPLICATION SYNDROME	0.00520749	0.5089138023942791
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.00520749	0.5089138023942791
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.00520749	0.5089138023942791
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.00520749	0.5089138023942791
PROLIDASE DEFICIENCY	0.00520749	0.5089138023942791
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.00520749	0.5089138023942791
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00520749	0.5089138023942791
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.00520749	0.5089138023942791
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00520749	0.5089138023942791
ALG11-CDG	0.00520749	0.5089138023942791
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.00520749	0.5089138023942791
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.00520749	0.5089138023942791
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.00520749	0.5089138023942791
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00520749	0.5089138023942791
16P13.2 MICRODELETION SYNDROME	0.00520749	0.5089138023942791
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.00520749	0.5089138023942791
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.00520749	0.5089138023942791
BETA-MANNOSIDOSIS	0.00520749	0.5089138023942791
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00520749	0.5089138023942791
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.00520749	0.5089138023942791
MENTAL RETARDATION, X-LINKED 102	0.00520749	0.5089138023942791
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00520749	0.5089138023942791
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.00520749	0.5089138023942791
CAMURATI-ENGELMANN DISEASE	0.00520749	0.5089138023942791
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.00520749	0.5089138023942791
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.00520749	0.5089138023942791
SPINOCEREBELLAR ATAXIA TYPE 13	0.00520749	0.5089138023942791
BRAIN-LUNG-THYROID SYNDROME	0.0051938	0.5075759160123988
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.0051938	0.5075759160123988
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.0051938	0.5075759160123988
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.0051938	0.5075759160123988
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.0051938	0.5075759160123988
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0051938	0.5075759160123988
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.0051938	0.5075759160123988
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.0051938	0.5075759160123988
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.0051938	0.5075759160123988
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.0051938	0.5075759160123988
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.00473934	0.46316277904312875
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.00473934	0.46316277904312875
FRANK-TER HAAR SYNDROME; FTHS	0.00473934	0.46316277904312875
COFFIN-SIRIS SYNDROME 5	0.00473934	0.46316277904312875
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.00473934	0.46316277904312875
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.00473934	0.46316277904312875
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.00473934	0.46316277904312875
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.00473934	0.46316277904312875
AICA-RIBOSIDURIA	0.00473934	0.46316277904312875
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.00473934	0.46316277904312875
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.00473934	0.46316277904312875
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00473934	0.46316277904312875
MECKEL SYNDROME, TYPE 1; MKS1	0.00473934	0.46316277904312875
MENTAL RETARDATION, X-LINKED 103	0.00473934	0.46316277904312875
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.00473934	0.46316277904312875
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.00473934	0.46316277904312875
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.00473934	0.46316277904312875
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.00473934	0.46316277904312875
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.00473934	0.46316277904312875
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.00473934	0.46316277904312875
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.00473934	0.46316277904312875
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.00473934	0.46316277904312875
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.00473934	0.46316277904312875
FRYNS SYNDROME	0.00473934	0.46316277904312875
2Q23.1 MICRODUPLICATION SYNDROME	0.00473934	0.46316277904312875
ADENYLOSUCCINASE DEFICIENCY	0.00473934	0.46316277904312875
1P21.3 MICRODELETION SYNDROME	0.00473934	0.46316277904312875
ZUNICH NEUROECTODERMAL SYNDROME	0.00473934	0.46316277904312875
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.00473934	0.46316277904312875
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.00473934	0.46316277904312875
ACROMELIC FRONTONASAL DYSPLASIA	0.00473934	0.46316277904312875
ARIMA SYNDROME	0.00473934	0.46316277904312875
PITT-HOPKINS SYNDROME	0.00473934	0.46316277904312875
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00473934	0.46316277904312875
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00473934	0.46316277904312875
FRANK-TER HAAR SYNDROME	0.00473934	0.46316277904312875
STROMME SYNDROME; STROMS	0.00473934	0.46316277904312875
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00473934	0.46316277904312875
ANGELMAN SYNDROME	0.00473934	0.46316277904312875
MOSAIC TRISOMY 14	0.00473934	0.46316277904312875
X-LINKED DOMINANT CHONDRODYSPLASIA, CHASSAING-LACOMBE TYPE	0.00473934	0.46316277904312875
TEEBI-SHALTOUT SYNDROME; TBSH	0.00473934	0.46316277904312875
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.00473934	0.46316277904312875
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.00473934	0.46316277904312875
DISTAL MONOSOMY 7Q36	0.00473934	0.46316277904312875
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.00473934	0.46316277904312875
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00473934	0.46316277904312875
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.00473934	0.46316277904312875
PMM2-CDG	0.00473934	0.46316277904312875
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.00473934	0.46316277904312875
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.00473934	0.46316277904312875
FRYNS SYNDROME; FRNS	0.00473934	0.46316277904312875
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.00473934	0.46316277904312875
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.00473934	0.46316277904312875
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00473934	0.46316277904312875
HALL-RIGGS SYNDROME	0.00473934	0.46316277904312875
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.00473934	0.46316277904312875
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.00473934	0.46316277904312875
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.00473934	0.46316277904312875
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00473934	0.46316277904312875
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.00473934	0.46316277904312875
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00473934	0.46316277904312875
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.00473934	0.46316277904312875
FRYNS-SMEETS-THIRY SYNDROME	0.00473934	0.46316277904312875
FLOATING-HARBOR SYNDROME	0.00473934	0.46316277904312875
TRANSALDOLASE DEFICIENCY	0.00473934	0.46316277904312875
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.00473934	0.46316277904312875
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.00473934	0.46316277904312875
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.00473934	0.46316277904312875
COFFIN-SIRIS SYNDROME 10; CSS10	0.00473934	0.46316277904312875
FLOATING-HARBOR SYNDROME	0.00473934	0.46316277904312875
CEREBROFACIOTHORACIC DYSPLASIA	0.00473934	0.46316277904312875
ANGELMAN SYNDROME	0.00473934	0.46316277904312875
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.00473934	0.46316277904312875
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00473934	0.46316277904312875
TRICHOHEPATOENTERIC SYNDROME 1	0.00473934	0.46316277904312875
COACH SYNDROME	0.00473934	0.46316277904312875
C SYNDROME	0.00473934	0.46316277904312875
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.00473934	0.46316277904312875
HELSMOORTEL-VAN DER AA SYNDROME	0.00473934	0.46316277904312875
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00473934	0.46316277904312875
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.00473934	0.46316277904312875
COFFIN-SIRIS SYNDROME 2; CSS2	0.00473934	0.46316277904312875
FACIOCARDIOMELIC SYNDROME	0.00473934	0.46316277904312875
CHUDLEY-LOWRY-HOAR SYNDROME	0.00473934	0.46316277904312875
TEMPLE-BARAITSER SYNDROME	0.00473934	0.46316277904312875
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00473934	0.46316277904312875
SMITH-FINEMAN-MYERS SYNDROME	0.00473934	0.46316277904312875
TEMPLE-BARAITSER SYNDROME; TMBTS	0.00473934	0.46316277904312875
TRIPLOIDY	0.00473934	0.46316277904312875
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.00473934	0.46316277904312875
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00473934	0.46316277904312875
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.00473934	0.46316277904312875
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.00473934	0.46316277904312875
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.00473934	0.46316277904312875
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.00473934	0.46316277904312875
ALAZAMI SYNDROME; ALAZS	0.00473934	0.46316277904312875
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.00473934	0.46316277904312875
16P12.1P12.3 TRIPLICATION SYNDROME	0.00473934	0.46316277904312875
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.00473934	0.46316277904312875
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.00473934	0.46316277904312875
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.00473934	0.46316277904312875
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00378788	0.3701791868660798
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00378788	0.3701791868660798
PREMATURE CENTROMERE DIVISION; PCD	0.00378788	0.3701791868660798
APOLIPOPROTEIN(A)	0.00378788	0.3701791868660798
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00378788	0.3701791868660798
EPILEPSY, PYRIDOXINE-DEPENDENT	0.00378788	0.3701791868660798
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00378788	0.3701791868660798
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00378788	0.3701791868660798
GLUTATHIONURIA	0.00378788	0.3701791868660798
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00378788	0.3701791868660798
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00378788	0.3701791868660798
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00378788	0.3701791868660798
MACROCYTOSIS, FAMILIAL	0.00378788	0.3701791868660798
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00378788	0.3701791868660798
DERMATITIS, ATOPIC	0.00378788	0.3701791868660798
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00378788	0.3701791868660798
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00378788	0.3701791868660798
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00378788	0.3701791868660798
WHITE SPONGE NEVUS OF CANNON	0.00378788	0.3701791868660798
CHOROIDAL OSTEOMA, BILATERAL	0.00378788	0.3701791868660798
ONCOCYTOMA	0.00378788	0.3701791868660798
ACETYLATION, SLOW	0.00378788	0.3701791868660798
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.00378788	0.3701791868660798
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.00378788	0.3701791868660798
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00378788	0.3701791868660798
PROGESTERONE RESISTANCE	0.00378788	0.3701791868660798
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00378788	0.3701791868660798
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00378788	0.3701791868660798
GAPO SYNDROME; GAPOS	0.00378788	0.3701791868660798
ZINC, ELEVATED PLASMA	0.00378788	0.3701791868660798
ALAND ISLAND EYE DISEASE	0.00378788	0.3701791868660798
LUTHERAN SUPPRESSOR, X-LINKED	0.00378788	0.3701791868660798
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00378788	0.3701791868660798
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00378788	0.3701791868660798
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00378788	0.3701791868660798
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00378788	0.3701791868660798
TESTICULAR GERM CELL TUMOR; TGCT	0.00378788	0.3701791868660798
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.00378788	0.3701791868660798
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00378788	0.3701791868660798
CEPHALIN LIPIDOSIS	0.00378788	0.3701791868660798
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00378788	0.3701791868660798
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00378788	0.3701791868660798
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00378788	0.3701791868660798
PARAOXONASE 1	0.00378788	0.3701791868660798
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00378788	0.3701791868660798
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00378788	0.3701791868660798
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00378788	0.3701791868660798
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00378788	0.3701791868660798
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00378788	0.3701791868660798
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.00378788	0.3701791868660798
CITRULLINE TRANSPORT DEFECT	0.00378788	0.3701791868660798
MACULAR CORNEAL DYSTROPHY	0.00378788	0.3701791868660798
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00378788	0.3701791868660798
T-SUBSTANCE ANOMALY	0.00378788	0.3701791868660798
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00378788	0.3701791868660798
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00378788	0.3701791868660798
BARTTER SYNDROME	0.00378788	0.3701791868660798
HOOFT DISEASE	0.00378788	0.3701791868660798
PROPERDIN DEFICIENCY, X-LINKED	0.00378788	0.3701791868660798
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00378788	0.3701791868660798
XANTHINURIA, TYPE I	0.00378788	0.3701791868660798
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00378788	0.3701791868660798
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00378788	0.3701791868660798
POLYCYSTIC OVARY SYNDROME 1	0.00378788	0.3701791868660798
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00378788	0.3701791868660798
GLUTATHIONE REDUCTASE	0.00378788	0.3701791868660798
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00378788	0.3701791868660798
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.00378788	0.3701791868660798
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.00378788	0.3701791868660798
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00378788	0.3701791868660798
CARBOXYLESTERASE 1	0.00378788	0.3701791868660798
CARDIAC LIPIDOSIS, FAMILIAL	0.00378788	0.3701791868660798
HEINZ BODY ANEMIAS	0.00378788	0.3701791868660798
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00378788	0.3701791868660798
HYPERPROGLUCAGONEMIA	0.00378788	0.3701791868660798
DELETED IN AZOOSPERMIA	0.00378788	0.3701791868660798
LARSEN-LIKE SYNDROME	0.00378788	0.3701791868660798
PERRY SYNDROME	0.00378788	0.3701791868660798
REVESZ SYNDROME	0.00378788	0.3701791868660798
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00378788	0.3701791868660798
MACULAR DYSTROPHY, CORNEAL, 1	0.00378788	0.3701791868660798
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00378788	0.3701791868660798
OSTEOMESOPYKNOSIS	0.00378788	0.3701791868660798
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00378788	0.3701791868660798
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00378788	0.3701791868660798
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00378788	0.3701791868660798
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00378788	0.3701791868660798
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00378788	0.3701791868660798
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00378788	0.3701791868660798
CATECHOL-O-METHYLTRANSFERASE	0.00378788	0.3701791868660798
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00378788	0.3701791868660798
FLOOD FACTOR DEFICIENCY	0.00378788	0.3701791868660798
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00378788	0.3701791868660798
NORMOKALEMIC PERIODIC PARALYSIS	0.00378788	0.3701791868660798
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00378788	0.3701791868660798
GONADOBLASTOMA	0.00378788	0.3701791868660798
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00378788	0.3701791868660798
HYPOASCORBEMIA	0.00378788	0.3701791868660798
PREMATURE OVARIAN FAILURE 1	0.00378788	0.3701791868660798
XM SYSTEM	0.00378788	0.3701791868660798
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00378788	0.3701791868660798
CEREBELLOPARENCHYMAL DISORDER V	0.00378788	0.3701791868660798
LIPASE DEFICIENCY, COMBINED	0.00378788	0.3701791868660798
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00378788	0.3701791868660798
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00378788	0.3701791868660798
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00378788	0.3701791868660798
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00378788	0.3701791868660798
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.00378788	0.3701791868660798
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.00378788	0.3701791868660798
LACTOSE INTOLERANCE, ADULT TYPE	0.00378788	0.3701791868660798
SERTOLI CELL-ONLY SYNDROME	0.00378788	0.3701791868660798
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00378788	0.3701791868660798
MAGNESIUM, ELEVATED RED CELL	0.00378788	0.3701791868660798
SCHIZOPHRENIA 4	0.00378788	0.3701791868660798
LYMPHOKINE DEFICIENCY	0.00378788	0.3701791868660798
DERMATOLEUKODYSTROPHY	0.00378788	0.3701791868660798
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00378788	0.3701791868660798
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00378788	0.3701791868660798
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.00378788	0.3701791868660798
ETHANOLAMINOSIS	0.00378788	0.3701791868660798
CALVARIAL HYPEROSTOSIS	0.00378788	0.3701791868660798
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00378788	0.3701791868660798
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00378788	0.3701791868660798
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00378788	0.3701791868660798
SALLA DISEASE	0.00378788	0.3701791868660798
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00378788	0.3701791868660798
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00378788	0.3701791868660798
X-LINKED ADRENOLEUKODYSTROPHY	0.00378788	0.3701791868660798
FINGERPRINT BODY MYOPATHY	0.00378788	0.3701791868660798
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00378788	0.3701791868660798
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.00378788	0.3701791868660798
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00378788	0.3701791868660798
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00378788	0.3701791868660798
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00378788	0.3701791868660798
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00378788	0.3701791868660798
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.00378788	0.3701791868660798
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00378788	0.3701791868660798
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.00378788	0.3701791868660798
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00378788	0.3701791868660798
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00378788	0.3701791868660798
COUMARIN RESISTANCE	0.00378788	0.3701791868660798
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00378788	0.3701791868660798
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00378788	0.3701791868660798
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00378788	0.3701791868660798
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00378788	0.3701791868660798
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00378788	0.3701791868660798
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00378788	0.3701791868660798
MYELOPEROXIDASE DEFICIENCY	0.00378788	0.3701791868660798
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00378788	0.3701791868660798
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00378788	0.3701791868660798
EHLERS-DANLOS SYNDROME, TYPE VI	0.00378788	0.3701791868660798
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.00378788	0.3701791868660798
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00378788	0.3701791868660798
CUTIS LAXA	0.00378788	0.3701791868660798
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00378788	0.3701791868660798
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00378788	0.3701791868660798
URATE-BINDING GLOBULIN, DECREASE IN	0.00378788	0.3701791868660798
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00378788	0.3701791868660798
OSTEOGENESIS IMPERFECTA, TYPE V	0.00378788	0.3701791868660798
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00378788	0.3701791868660798
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00378788	0.3701791868660798
OSTEOGENIC SARCOMA	0.00378788	0.3701791868660798
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00378788	0.3701791868660798
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00378788	0.3701791868660798
SPERMATOGENIC FAILURE 1; SPGF1	0.00378788	0.3701791868660798
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00378788	0.3701791868660798
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00378788	0.3701791868660798
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00378788	0.3701791868660798
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00378788	0.3701791868660798
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00378788	0.3701791868660798
BEETURIA	0.00378788	0.3701791868660798
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00378788	0.3701791868660798
OVARIAN CANCER	0.00378788	0.3701791868660798
BLOOD GROUP, DUFFY SYSTEM; FY	0.00378788	0.3701791868660798
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00378788	0.3701791868660798
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.00378788	0.3701791868660798
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00378788	0.3701791868660798
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00378788	0.3701791868660798
ICHTHYOSIS, X-LINKED	0.00378788	0.3701791868660798
PITUITARY DWARFISM IV	0.00378788	0.3701791868660798
CONGENITAL ADRENAL HYPERPLASIA	0.00378788	0.3701791868660798
NEUTROPHIL ACTIN DYSFUNCTION	0.00378788	0.3701791868660798
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00378788	0.3701791868660798
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00378788	0.3701791868660798
MYOPATHY, SPHEROID BODY	0.00378788	0.3701791868660798
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00378788	0.3701791868660798
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00378788	0.3701791868660798
PACMAN DYSPLASIA	0.00378788	0.3701791868660798
ICHTHYOSIS AND MALE HYPOGONADISM	0.00378788	0.3701791868660798
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00378788	0.3701791868660798
SPINAL ARACHNOIDITIS	0.00378788	0.3701791868660798
257960 OCULOTRICHODYSPLASIA; OTD	0.00378788	0.3701791868660798
LARON SYNDROME	0.00378788	0.3701791868660798
OCULORENOCEREBELLAR SYNDROME	0.00378788	0.3701791868660798
HOLOPROSENCEPHALY 5; HPE5	0.00369004	0.3606175503720575
MEGAEPIPHYSEAL DWARFISM	0.00369004	0.3606175503720575
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.00369004	0.3606175503720575
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00369004	0.3606175503720575
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.00369004	0.3606175503720575
ROIFMAN-CHITAYAT SYNDROME	0.00369004	0.3606175503720575
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.00369004	0.3606175503720575
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.00369004	0.3606175503720575
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.00369004	0.3606175503720575
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.00369004	0.3606175503720575
ATELOSTEOGENESIS TYPE II	0.00369004	0.3606175503720575
RING CHROMOSOME 12 SYNDROME	0.00369004	0.3606175503720575
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.00369004	0.3606175503720575
CRISS-CROSS HEART	0.00369004	0.3606175503720575
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.00369004	0.3606175503720575
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.00369004	0.3606175503720575
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00369004	0.3606175503720575
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.00369004	0.3606175503720575
601095 HARROD SYNDROME	0.00369004	0.3606175503720575
6Q TERMINAL DELETION SYNDROME	0.00369004	0.3606175503720575
MONOSOMY 13Q34	0.00369004	0.3606175503720575
MATERNAL PHENYLKETONURIA	0.00369004	0.3606175503720575
RIDDLE SYNDROME	0.00369004	0.3606175503720575
DIAMOND-BLACKFAN ANEMIA 4	0.00369004	0.3606175503720575
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.00369004	0.3606175503720575
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.00369004	0.3606175503720575
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00369004	0.3606175503720575
CHROMOSOME 16P13.3 DELETION SYNDROME	0.00369004	0.3606175503720575
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.00369004	0.3606175503720575
49,XXXYY SYNDROME	0.00369004	0.3606175503720575
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.00369004	0.3606175503720575
CROUZON DISEASE	0.00369004	0.3606175503720575
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.00369004	0.3606175503720575
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00369004	0.3606175503720575
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.00369004	0.3606175503720575
COG1-CDG	0.00369004	0.3606175503720575
LICHTENSTEIN SYNDROME	0.00369004	0.3606175503720575
RODRIGUES BLINDNESS	0.00369004	0.3606175503720575
HOLMES-GANG SYNDROME	0.00369004	0.3606175503720575
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.00369004	0.3606175503720575
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00369004	0.3606175503720575
MCDONOUGH SYNDROME	0.00369004	0.3606175503720575
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00369004	0.3606175503720575
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.00369004	0.3606175503720575
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.00369004	0.3606175503720575
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.00369004	0.3606175503720575
OROFACIODIGITAL SYNDROME TYPE 14	0.00369004	0.3606175503720575
ADENYLOSUCCINATE LYASE DEFICIENCY	0.00369004	0.3606175503720575
RING CHROMOSOME 13 SYNDROME	0.00369004	0.3606175503720575
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00369004	0.3606175503720575
ZECHI-CEIDE SYNDROME	0.00369004	0.3606175503720575
ISOLATED AGAMMAGLOBULINEMIA	0.00369004	0.3606175503720575
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.00369004	0.3606175503720575
KENNERKNECHT SYNDROME	0.00369004	0.3606175503720575
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00369004	0.3606175503720575
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.00369004	0.3606175503720575
CONO-SPONDYLAR DYSPLASIA	0.00369004	0.3606175503720575
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.00369004	0.3606175503720575
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.00369004	0.3606175503720575
MENTAL RETARDATION, X-LINKED 91; MRX91	0.00369004	0.3606175503720575
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00369004	0.3606175503720575
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.00369004	0.3606175503720575
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.00369004	0.3606175503720575
JABERI-ELAHI SYNDROME; JABELS	0.00369004	0.3606175503720575
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.00369004	0.3606175503720575
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.00369004	0.3606175503720575
HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES; HYC3	0.00369004	0.3606175503720575
WAARDENBURG SYNDROME	0.00369004	0.3606175503720575
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.00369004	0.3606175503720575
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.00369004	0.3606175503720575
SYNDROMIC DIARRHEA	0.00369004	0.3606175503720575
IMMUNODEFICIENCY 55; IMD55	0.00369004	0.3606175503720575
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.00369004	0.3606175503720575
COFFIN-SIRIS SYNDROME 6; CSS6	0.00369004	0.3606175503720575
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.00369004	0.3606175503720575
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00369004	0.3606175503720575
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.00369004	0.3606175503720575
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.00369004	0.3606175503720575
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.00369004	0.3606175503720575
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO JAK3 DEFICIENCY	0.00369004	0.3606175503720575
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00369004	0.3606175503720575
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.00369004	0.3606175503720575
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.00369004	0.3606175503720575
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.00369004	0.3606175503720575
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.00369004	0.3606175503720575
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.00369004	0.3606175503720575
FREE SIALIC ACID STORAGE DISEASE	0.00369004	0.3606175503720575
ISOLATED BILIARY ATRESIA	0.00369004	0.3606175503720575
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.00369004	0.3606175503720575
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.00369004	0.3606175503720575
WILSON-TURNER SYNDROME	0.00369004	0.3606175503720575
JOUBERT SYNDROME 35; JBTS35	0.00369004	0.3606175503720575
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00369004	0.3606175503720575
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.00369004	0.3606175503720575
KLEEFSTRA SYNDROME 2; KLEFS2	0.00369004	0.3606175503720575
SAGLIKER SYNDROME	0.00369004	0.3606175503720575
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.00369004	0.3606175503720575
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00369004	0.3606175503720575
CHROMOSOME 16P13.2 DELETION SYNDROME	0.00369004	0.3606175503720575
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.00369004	0.3606175503720575
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.00369004	0.3606175503720575
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00369004	0.3606175503720575
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.00369004	0.3606175503720575
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.00369004	0.3606175503720575
OROFACIODIGITAL SYNDROME XIV; OFD14	0.00369004	0.3606175503720575
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.00369004	0.3606175503720575
SRD5A3-CDG	0.00369004	0.3606175503720575
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00369004	0.3606175503720575
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.00369004	0.3606175503720575
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.00369004	0.3606175503720575
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.00369004	0.3606175503720575
DUPLICATION/INVERSION 15Q11	0.00369004	0.3606175503720575
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.00369004	0.3606175503720575
SAY-BARBER-MILLER SYNDROME	0.00369004	0.3606175503720575
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00369004	0.3606175503720575
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.00369004	0.3606175503720575
7P22.1 MICRODUPLICATION SYNDROME	0.00369004	0.3606175503720575
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00369004	0.3606175503720575
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.00369004	0.3606175503720575
CEREBROFACIOARTICULAR SYNDROME	0.00369004	0.3606175503720575
MENTAL RETARDATION, X-LINKED 100	0.00369004	0.3606175503720575
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.00369004	0.3606175503720575
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.00369004	0.3606175503720575
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.00369004	0.3606175503720575
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.00369004	0.3606175503720575
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.00369004	0.3606175503720575
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.00369004	0.3606175503720575
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.00369004	0.3606175503720575
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00369004	0.3606175503720575
MILROY DISEASE	0.00369004	0.3606175503720575
SÉZARY SYNDROME	0.00369004	0.3606175503720575
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.00369004	0.3606175503720575
HIRSCHSPRUNG DISEASE WITH HYPOPLASTIC NAILS AND DYSMORPHIC FACIALFEATURES	0.00369004	0.3606175503720575
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00369004	0.3606175503720575
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.00369004	0.3606175503720575
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.00369004	0.3606175503720575
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.00369004	0.3606175503720575
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00369004	0.3606175503720575
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.00369004	0.3606175503720575
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.00369004	0.3606175503720575
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.00369004	0.3606175503720575
TRANSALDOLASE DEFICIENCY	0.00369004	0.3606175503720575
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.00369004	0.3606175503720575
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.00369004	0.3606175503720575
MENTAL RETARDATION, X-LINKED 14	0.00369004	0.3606175503720575
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.00369004	0.3606175503720575
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.00369004	0.3606175503720575
JUVENILE POLYPOSIS SYNDROME	0.00369004	0.3606175503720575
IRIDOGONIODYSGENESIS, TYPE 2	0.00369004	0.3606175503720575
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33	0.00369004	0.3606175503720575
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00369004	0.3606175503720575
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.00369004	0.3606175503720575
HAIRY ELBOWS	0.00369004	0.3606175503720575
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.00369004	0.3606175503720575
FOCAL FACIAL DERMAL DYSPLASIA TYPE I	0.00369004	0.3606175503720575
UROFACIAL SYNDROME	0.00369004	0.3606175503720575
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.00369004	0.3606175503720575
EPIDERMAL NEVUS SYNDROME	0.00369004	0.3606175503720575
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.00369004	0.3606175503720575
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.00369004	0.3606175503720575
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.00369004	0.3606175503720575
11P15.4 MICRODUPLICATION SYNDROME	0.00369004	0.3606175503720575
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.00369004	0.3606175503720575
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.00369004	0.3606175503720575
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.00369004	0.3606175503720575
JUVENILE POLYPOSIS OF INFANCY	0.00369004	0.3606175503720575
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00369004	0.3606175503720575
COWCHOCK SYNDROME; COWCK	0.00302121	0.29525461766256295
BRANCHIOOCULOFACIAL SYNDROME	0.00302121	0.29525461766256295
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.00302121	0.29525461766256295
MUENKE SYNDROME	0.00302121	0.29525461766256295
DEAFNESS, AUTOSOMAL RECESSIVE 29	0.00302121	0.29525461766256295
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00302121	0.29525461766256295
RICHARDS-RUNDLE SYNDROME; RRNS	0.00302121	0.29525461766256295
DEAFNESS, AUTOSOMAL RECESSIVE 20; DFNB20	0.00302121	0.29525461766256295
DESANTO-SHINAWI SYNDROME	0.00302121	0.29525461766256295
MONOSOMY 22Q13.3	0.00151745	0.14829625202222163
DIASTROPHIC DWARFISM	0.00151745	0.14829625202222163
HYDROXYKYNURENINURIA	0.00151745	0.14829625202222163
ALPHA-MANNOSIDOSIS	0.00151745	0.14829625202222163
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.00151745	0.14829625202222163
CENANI-LENZ SYNDROME	0.00151745	0.14829625202222163
MICROTRIPLICATION 11Q24.1	0.00151745	0.14829625202222163
TIETZ SYNDROME	0.00151745	0.14829625202222163
6P22 MICRODELETION SYNDROME	0.00151745	0.14829625202222163
16P11.2P12.2 MICRODELETION SYNDROME	0.00151745	0.14829625202222163
3MC SYNDROME 3	0.00151745	0.14829625202222163
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.00151745	0.14829625202222163
MAYER-ROKITANSKY-KÜSTER-HAUSER SYNDROME TYPE 2	0.00151745	0.14829625202222163
184705 STEINFELD SYNDROME	0.00151745	0.14829625202222163
3Q29 MICRODUPLICATION SYNDROME	0.00151745	0.14829625202222163
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00151745	0.14829625202222163
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.00151745	0.14829625202222163
WALDENSTRÖM MACROGLOBULINEMIA	0.00151745	0.14829625202222163
17Q23.1Q23.2 MICRODELETION SYNDROME	0.00151745	0.14829625202222163
RETICULAR DYSGENESIS	0.00151745	0.14829625202222163
TUNE DEAFNESS	0.00151745	0.14829625202222163
8Q21.11 MICRODELETION SYNDROME	0.00151745	0.14829625202222163
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.00151745	0.14829625202222163
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.00151745	0.14829625202222163
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.00151745	0.14829625202222163
PIEBALDISM	0.00151745	0.14829625202222163
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.00151745	0.14829625202222163
NEUROFIBROMATOSIS TYPE 1	0.00151745	0.14829625202222163
PILI TORTI	0.00151745	0.14829625202222163
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.00151745	0.14829625202222163
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.00151745	0.14829625202222163
SLC39A8-CDG	0.00151745	0.14829625202222163
RETINAL VENOUS BEADING	0.00151745	0.14829625202222163
SMITH-MAGENIS SYNDROME; SMS	0.00151745	0.14829625202222163
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00151745	0.14829625202222163
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.00151745	0.14829625202222163
TARP SYNDROME	0.00151745	0.14829625202222163
RECOMBINANT CHROMOSOME 8 SYNDROME	0.00151745	0.14829625202222163
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.00151745	0.14829625202222163
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00151745	0.14829625202222163
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00151745	0.14829625202222163
CARDIOAUDITORY SYNDROME OF SANCHEZ CASCOS	0.00151745	0.14829625202222163
EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS	0.00151745	0.14829625202222163
MEIER-GORLIN SYNDROME 1; MGORS1	0.00151745	0.14829625202222163
ISOLATED ANORECTAL MALFORMATION	0.00151745	0.14829625202222163
DYSOSTEOSCLEROSIS	0.00151745	0.14829625202222163
OSTEOGENESIS IMPERFECTA, TYPE IV	0.00151745	0.14829625202222163
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.00151745	0.14829625202222163
THALIDOMIDE EMBRYOPATHY	0.00151745	0.14829625202222163
EAR-PATELLA-SHORT STATURE SYNDROME	0.00151745	0.14829625202222163
PULMONIC STENOSIS AND DEAFNESS	0.00151745	0.14829625202222163
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.00151745	0.14829625202222163
CORNEODERMATOOSSEOUS SYNDROME	0.00151745	0.14829625202222163
OHDO SYNDROME	0.00151745	0.14829625202222163
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.00151745	0.14829625202222163
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.00151745	0.14829625202222163
GALACTOSIALIDOSIS	0.00151745	0.14829625202222163
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.00151745	0.14829625202222163
YUNIS-VARON SYNDROME	0.00151745	0.14829625202222163
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00151745	0.14829625202222163
ISOLATED BRACHYCEPHALY	0.00151745	0.14829625202222163
MUCOPOLYSACCHARIDOSIS TYPE 6	0.00151745	0.14829625202222163
MOEBIUS SYNDROME	0.00151745	0.14829625202222163
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.00151745	0.14829625202222163
MUCOPOLYSACCHARIDOSIS TYPE 3	0.00151745	0.14829625202222163
KEUTEL SYNDROME; KTLS	0.00151745	0.14829625202222163
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.00151745	0.14829625202222163
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.00151745	0.14829625202222163
KRABBE DISEASE	0.00151745	0.14829625202222163
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00151745	0.14829625202222163
MYASTHENIA GRAVIS	0.00151745	0.14829625202222163
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.00151745	0.14829625202222163
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.00151745	0.14829625202222163
GRACILE SYNDROME	0.00151745	0.14829625202222163
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.00151745	0.14829625202222163
SPINOCEREBELLAR ATAXIA TYPE 36	0.00151745	0.14829625202222163
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	0.00151745	0.14829625202222163
GLYCOGEN STORAGE DISEASE II	0.00151745	0.14829625202222163
CONGENITAL HYPOTHYROIDISM	0.00151745	0.14829625202222163
HSD10 DISEASE	0.00151745	0.14829625202222163
PAGET DISEASE OF BONE 3; PDB3	0.00151745	0.14829625202222163
FUCOSIDOSIS	0.00151745	0.14829625202222163
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.00151745	0.14829625202222163
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00151745	0.14829625202222163
PITUITARY CARCINOMA	0.00151745	0.14829625202222163
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.00151745	0.14829625202222163
ANUS, IMPERFORATE	0.00151745	0.14829625202222163
KNIEST DYSPLASIA	0.00151745	0.14829625202222163
CHIME SYNDROME	0.00151745	0.14829625202222163
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.00151745	0.14829625202222163
THANATOPHORIC DYSPLASIA	0.00151745	0.14829625202222163
JUVENILE PAGET DISEASE	0.00151745	0.14829625202222163
KEARNS-SAYRE SYNDROME	0.00151745	0.14829625202222163
VIRAL HEMORRHAGIC FEVER	0.00151745	0.14829625202222163
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.00151745	0.14829625202222163
13Q12.3 MICRODELETION SYNDROME	0.00151745	0.14829625202222163
NAIL-PATELLA SYNDROME	0.00151745	0.14829625202222163
GAUCHER DISEASE	0.00151745	0.14829625202222163
DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA	0.00151745	0.14829625202222163
YUNIS-VARON SYNDROME	0.00151745	0.14829625202222163
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.00151745	0.14829625202222163
FANCONI ANEMIA	0.00151745	0.14829625202222163
2P15P16.1 MICRODELETION SYNDROME	0.00151745	0.14829625202222163
GYRATE ATROPHY OF CHOROID AND RETINA	0.00151745	0.14829625202222163
SEVERE CANAVAN DISEASE	0.00151745	0.14829625202222163
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.00151745	0.14829625202222163
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.00151745	0.14829625202222163
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.00151745	0.14829625202222163
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.00151745	0.14829625202222163
OSTEOPETROSIS AND RELATED DISORDERS	0.00151745	0.14829625202222163
185750 SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00151745	0.14829625202222163
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00151745	0.14829625202222163
20Q11.2 MICRODELETION SYNDROME	0.00151745	0.14829625202222163
LATHOSTEROLOSIS	0.00151745	0.14829625202222163
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00151745	0.14829625202222163
CRANIOPHARYNGIOMA	0.00151745	0.14829625202222163
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.00151745	0.14829625202222163
ALBERS-SCHÖNBERG OSTEOPETROSIS	0.00151745	0.14829625202222163
HEREDITARY ACROKERATOTIC POIKILODERMA	0.00151745	0.14829625202222163
HIRSCHSPRUNG DISEASE WITH POLYDACTYLY, RENAL AGENESIS, AND DEAFNESS	0.00151745	0.14829625202222163
DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM	0.00151745	0.14829625202222163
CHAR SYNDROME	0.00151745	0.14829625202222163
BRITTLE CORNEA SYNDROME	0.00151745	0.14829625202222163
TRANSKETOLASE DEFICIENCY	0.00151745	0.14829625202222163
3MC SYNDROME	0.00151745	0.14829625202222163
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.00151745	0.14829625202222163
FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2	0.00151745	0.14829625202222163
OSTEOGENESIS IMPERFECTA, TYPE I	0.00151745	0.14829625202222163
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.00151745	0.14829625202222163
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.00151745	0.14829625202222163
HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17	0.00151745	0.14829625202222163
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	0.00151745	0.14829625202222163
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	0.00151745	0.14829625202222163
HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21	0.00151745	0.14829625202222163
BRANCHIOOTIC SYNDROME 2	0.00151745	0.14829625202222163
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.00151745	0.14829625202222163
121450 CORNEAL DEGENERATION, RIBBONLIKE, WITH DEAFNESS;;BAND KERATOPATHY WITH DEAFNESS	0.00151745	0.14829625202222163
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.00151745	0.14829625202222163
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.00151745	0.14829625202222163
%614187 HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS; HPPD	0.00151745	0.14829625202222163
X-LINKED HYPOPHOSPHATEMIA	0.00151745	0.14829625202222163
%615649 DEAFNESS, AUTOSOMAL DOMINANT 54; DFNA54	0.00151745	0.14829625202222163
%615654 DEAFNESS, AUTOSOMAL DOMINANT 58; DFNA58	0.00151745	0.14829625202222163
WAARDENBURG-SHAH SYNDROME	0.00151745	0.14829625202222163
WAARDENBURG SYNDROME TYPE 3	0.00151745	0.14829625202222163
BARDET-BIEDL SYNDROME 16; BBS16	0.00151745	0.14829625202222163
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00151745	0.14829625202222163
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.00151745	0.14829625202222163
COXOAURICULAR SYNDROME	0.00151745	0.14829625202222163
LISSENCEPHALY 5; LIS5	0.00151745	0.14829625202222163
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.00151745	0.14829625202222163
RENPENNING SYNDROME 1; RENS1	0.00151745	0.14829625202222163
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.00151745	0.14829625202222163
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.00151745	0.14829625202222163
DEMENTIA, FAMILIAL DANISH	0.00151745	0.14829625202222163
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.00151745	0.14829625202222163
%614414 DEAFNESS, AUTOSOMAL RECESSIVE 96; DFNB96	0.00151745	0.14829625202222163
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.00151745	0.14829625202222163
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.00151745	0.14829625202222163
%614617 DEAFNESS, AUTOSOMAL RECESSIVE 86; DFNB86	0.00151745	0.14829625202222163
BONE MARROW FAILURE SYNDROME 1; BMFS1	0.00151745	0.14829625202222163
N SYNDROME	0.00151745	0.14829625202222163
MUCOPOLYSACCHARIDOSIS, TYPE II	0.00151745	0.14829625202222163
MICROPHTHALMIA, SYNDROMIC 1	0.00151745	0.14829625202222163
CHIARI MALFORMATION TYPE I	0.00151745	0.14829625202222163
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.00151745	0.14829625202222163
OTOPALATODIGITAL SYNDROME TYPE 2	0.00151745	0.14829625202222163
OTOPALATODIGITAL SYNDROME TYPE 1	0.00151745	0.14829625202222163
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.00151745	0.14829625202222163
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.00151745	0.14829625202222163
CLEIDOCRANIAL DYSPLASIA; CCD	0.00151745	0.14829625202222163
DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B	0.00151745	0.14829625202222163
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00151745	0.14829625202222163
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.00151745	0.14829625202222163
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.00151745	0.14829625202222163
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00151745	0.14829625202222163
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.00151745	0.14829625202222163
MEIER-GORLIN SYNDROME 7	0.00151745	0.14829625202222163
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.00151745	0.14829625202222163
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.00151745	0.14829625202222163
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.00151745	0.14829625202222163
BRESEK SYNDROME	0.00151745	0.14829625202222163
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00151745	0.14829625202222163
SIFRIM-HITZ-WEISS SYNDROME	0.00151745	0.14829625202222163
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00151745	0.14829625202222163
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.00151745	0.14829625202222163
OPTIC ATROPHY 11; OPA11	0.00151745	0.14829625202222163
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.00151745	0.14829625202222163
KEUTEL SYNDROME	0.00151745	0.14829625202222163
CILIARY DYSKINESIA, PRIMARY, 37; CILD37	0.00151745	0.14829625202222163
GENITOPATELLAR SYNDROME	0.00151745	0.14829625202222163
DEAFNESS, AUTOSOMAL RECESSIVE 106; DFNB106	0.00151745	0.14829625202222163
DEAFNESS, AUTOSOMAL RECESSIVE 107; DFNB107	0.00151745	0.14829625202222163
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.00151745	0.14829625202222163
CAMPTODACTYLY-TALL STATURE-SCOLIOSIS-HEARING LOSS SYNDROME	0.00151745	0.14829625202222163
DEAFNESS, X-LINKED 7; DFNX7	0.00151745	0.14829625202222163
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.00151745	0.14829625202222163
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.00151745	0.14829625202222163
LYMPHEDEMA, HEREDITARY, III	0.00151745	0.14829625202222163
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.00151745	0.14829625202222163
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.00151745	0.14829625202222163
CHARGE-LIKE SYNDROME, X-LINKED	0.00151745	0.14829625202222163
CHOPS SYNDROME; CHOPS	0.00151745	0.14829625202222163
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.00151745	0.14829625202222163
TURNER SYNDROME	0.00151745	0.14829625202222163
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.00151745	0.14829625202222163
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.00151745	0.14829625202222163
SIALIDOSIS TYPE 2	0.00151745	0.14829625202222163
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00151745	0.14829625202222163
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.00151745	0.14829625202222163
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00151745	0.14829625202222163
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.00151745	0.14829625202222163
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.00151745	0.14829625202222163
CONGENITAL TOXOPLASMOSIS	0.00151745	0.14829625202222163
AGEL AMYLOIDOSIS	0.00151745	0.14829625202222163
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.00151745	0.14829625202222163
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.00151745	0.14829625202222163
FRIED SYNDROME	0.00151745	0.14829625202222163
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.00151745	0.14829625202222163
BRITTLE CORNEA SYNDROME 2; BCS2	0.00151745	0.14829625202222163
DEAFNESS, AUTOSOMAL DOMINANT 73; DFNA73	0.00151745	0.14829625202222163
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00151745	0.14829625202222163
PIERPONT SYNDROME	0.00151745	0.14829625202222163
SPINOCEREBELLAR ATAXIA TYPE 18	0.00151745	0.14829625202222163
NEUROFIBROMATOSIS, TYPE II	0.00151745	0.14829625202222163
BOHRING-OPITZ SYNDROME	0.00151745	0.14829625202222163
CARNEY-STRATAKIS SYNDROME	0.00151745	0.14829625202222163
OTOSCLEROSIS 3; OTSC3	0.00151745	0.14829625202222163
PALLISTER-KILLIAN SYNDROME	0.00151745	0.14829625202222163
DEAFNESS, AUTOSOMAL RECESSIVE 32, WITH OR WITHOUT IMMOTILE SPERM; DFNB32	0.00151745	0.14829625202222163
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.00151745	0.14829625202222163
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.00151745	0.14829625202222163
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.00151745	0.14829625202222163
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00151745	0.14829625202222163
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.00151745	0.14829625202222163
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.00151745	0.14829625202222163
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.00151745	0.14829625202222163
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.00151745	0.14829625202222163
RECOMBINANT 8 SYNDROME	0.00151745	0.14829625202222163
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.00151745	0.14829625202222163
NON-DISTAL MONOSOMY 20Q	0.00151745	0.14829625202222163
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.00151745	0.14829625202222163
%607683 DEAFNESS, AUTOSOMAL DOMINANT 52; DFNA52;;DEAFNESS, AUTOSOMAL DOMINANT 42; DFNA42	0.00151745	0.14829625202222163
8P23.1 DUPLICATION SYNDROME	0.00151745	0.14829625202222163
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.00151745	0.14829625202222163
DEAFNESS, AUTOSOMAL RECESSIVE 33	0.00151745	0.14829625202222163
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.00151745	0.14829625202222163
PELIZAEUS-MERZBACHER DISEASE	0.00151745	0.14829625202222163
SPINOCEREBELLAR ATAXIA 13	0.00151745	0.14829625202222163
TRANSIENT NEONATAL DIABETES MELLITUS	0.00151745	0.14829625202222163
PERMANENT NEONATAL DIABETES MELLITUS	0.00151745	0.14829625202222163
LASSA FEVER	0.00151745	0.14829625202222163
TURCOT SYNDROME WITH POLYPOSIS	0.00151745	0.14829625202222163
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00151745	0.14829625202222163
MOSAIC MONOSOMY X	0.00151745	0.14829625202222163
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00151745	0.14829625202222163
MONOSOMY X	0.00151745	0.14829625202222163
GENITOPATELLAR SYNDROME; GTPTS	0.00151745	0.14829625202222163
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.00151745	0.14829625202222163
PHELAN-MCDERMID SYNDROME	0.00151745	0.14829625202222163
PAGET DISEASE OF BONE 4; PDB4	0.00151745	0.14829625202222163
DEAFNESS, AUTOSOMAL DOMINANT 24	0.00151745	0.14829625202222163
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.00151745	0.14829625202222163
HURLER SYNDROME	0.00151745	0.14829625202222163
MARSHALL-SMITH SYNDROME; MRSHSS	0.00151745	0.14829625202222163
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.00151745	0.14829625202222163
DISTAL MONOSOMY 6P	0.00151745	0.14829625202222163
DEAFNESS, AUTOSOMAL RECESSIVE 47	0.00151745	0.14829625202222163
HARDIKAR SYNDROME	0.00151745	0.14829625202222163
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.00151745	0.14829625202222163
HURLER SYNDROME	0.00151745	0.14829625202222163
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00151745	0.14829625202222163
PELVISCAPULAR DYSPLASIA	0.00151745	0.14829625202222163
TIBIAL HEMIMELIA	0.00151745	0.14829625202222163
THANATOPHORIC DYSPLASIA TYPE 2	0.00151745	0.14829625202222163
PFEIFFER SYNDROME TYPE 3	0.00151745	0.14829625202222163
PFEIFFER SYNDROME TYPE 1	0.00151745	0.14829625202222163
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.00151745	0.14829625202222163
DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84	0.00151745	0.14829625202222163
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.00151745	0.14829625202222163
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.00151745	0.14829625202222163
SPASTIC PARAPARESIS AND DEAFNESS	0.00151745	0.14829625202222163
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.00151745	0.14829625202222163
%613916 DEAFNESS, AUTOSOMAL RECESSIVE 89; DFNB89	0.00151745	0.14829625202222163
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00151745	0.14829625202222163
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00151745	0.14829625202222163
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00151745	0.14829625202222163
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00151745	0.14829625202222163
CYCLIC VOMITING SYNDROME	0.00151745	0.14829625202222163
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00151745	0.14829625202222163
DEAFNESS, AUTOSOMAL RECESSIVE 55	0.00151745	0.14829625202222163
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.00151745	0.14829625202222163
MOSAIC TRISOMY 8	0.00151745	0.14829625202222163
USHER SYNDROME, TYPE ID	0.00151745	0.14829625202222163
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.00151745	0.14829625202222163
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.00151745	0.14829625202222163
DEAFNESS, AUTOSOMAL RECESSIVE 65; DFNB65	0.00151745	0.14829625202222163
KLEEFSTRA SYNDROME	0.00151745	0.14829625202222163
ACROOSTEOLYSIS DOMINANT TYPE	0.00151745	0.14829625202222163
AUROCEPHALOSYNDACTYLY	0.00151745	0.14829625202222163
ABCD SYNDROME	0.00151745	0.14829625202222163
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.00151745	0.14829625202222163
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.00151745	0.14829625202222163
XFE PROGEROID SYNDROME; XFEPS	0.00151745	0.14829625202222163
USHER SYNDROME, TYPE IID; USH2D	0.00151745	0.14829625202222163
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 2	0.00151745	0.14829625202222163
ACRODYSOSTOSIS	0.00151745	0.14829625202222163
CAMPOMELIC DYSPLASIA	0.00151745	0.14829625202222163
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00151745	0.14829625202222163
OTOSCLEROSIS 8; OTSC8	0.00151745	0.14829625202222163
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.00151745	0.14829625202222163
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.00151745	0.14829625202222163
DEAFNESS, CONGENITAL, WITH KERATOPACHYDERMIA AND CONSTRICTIONS OFFINGERS AND TOES	0.00151745	0.14829625202222163
RHYNS SYNDROME	0.00151745	0.14829625202222163
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.00151745	0.14829625202222163
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.00151745	0.14829625202222163
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.00151745	0.14829625202222163
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.00151745	0.14829625202222163
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.00151745	0.14829625202222163
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00151745	0.14829625202222163
RENAL COLOBOMA SYNDROME	0.00151745	0.14829625202222163
MULTIPLE CARBOXYLASE DEFICIENCY	0.00151745	0.14829625202222163
HYPERTRICHOSIS LANUGINOSA CONGENITA	0.00151745	0.14829625202222163
SPINOCEREBELLAR ATAXIA TYPE 31	0.00151745	0.14829625202222163
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.00151745	0.14829625202222163
COXOAURICULAR SYNDROME	0.00151745	0.14829625202222163
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.00151745	0.14829625202222163
SENSORINEURAL DEAFNESS WITH DILATED CARDIOMYOPATHY	0.00151745	0.14829625202222163
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.00151745	0.14829625202222163
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.00151745	0.14829625202222163
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.00151745	0.14829625202222163
CLEIDOCRANIAL DYSPLASIA	0.00151745	0.14829625202222163
CANAVAN DISEASE	0.00151745	0.14829625202222163
CANAVAN DISEASE	0.00151745	0.14829625202222163
NEPHROSIS WITH DEAFNESS AND URINARY TRACT AND DIGITAL MALFORMATIONS	0.00151745	0.14829625202222163
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00151745	0.14829625202222163
BUSCHKE-OLLENDORFF SYNDROME	0.00151745	0.14829625202222163
OSTEOGENESIS IMPERFECTA	0.00151745	0.14829625202222163
ACQUIRED PARTIAL LIPODYSTROPHY	0.00151745	0.14829625202222163
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00151745	0.14829625202222163
ARACHNOIDITIS	0.00151745	0.14829625202222163
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.00151745	0.14829625202222163
CONGENITAL VELOPHARYNGEAL INCOMPETENCE	0.00151745	0.14829625202222163
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.00151745	0.14829625202222163
NATHALIE SYNDROME	0.00151745	0.14829625202222163
RUBINSTEIN-TAYBI SYNDROME	0.00151745	0.14829625202222163
AXENFELD-RIEGER SYNDROME	0.00151745	0.14829625202222163
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.00151745	0.14829625202222163
RICHARDS-RUNDLE SYNDROME	0.00151745	0.14829625202222163
CAMPOMELIC DYSPLASIA	0.00151745	0.14829625202222163
DISTAL MONOSOMY 10P	0.00151745	0.14829625202222163
IVIC SYNDROME	0.00151745	0.14829625202222163
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.00151745	0.14829625202222163
RAPADILINO SYNDROME	0.00151745	0.14829625202222163
DYSOSTEOSCLEROSIS	0.00151745	0.14829625202222163
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.00151745	0.14829625202222163
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00151745	0.14829625202222163
COWDEN SYNDROME	0.00151745	0.14829625202222163
MENIERE DISEASE	0.00151745	0.14829625202222163
HIDROTIC ECTODERMAL DYSPLASIA, HALAL TYPE	0.00151745	0.14829625202222163
CLEFT LIP WITH OR WITHOUT CLEFT PALATE	0.00151745	0.14829625202222163
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.00151745	0.14829625202222163
DISTAL MONOSOMY 15Q	0.00151745	0.14829625202222163
RAMON SYNDROME	0.00151745	0.14829625202222163
THANATOPHORIC DYSPLASIA TYPE 1	0.00151745	0.14829625202222163
PLAGUE	0.00151745	0.14829625202222163
3MC SYNDROME 2	0.00151745	0.14829625202222163
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.00151745	0.14829625202222163
FETAL METHYLMERCURY SYNDROME	0.00151745	0.14829625202222163
DIABETIC EMBRYOPATHY	0.00151745	0.14829625202222163
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.00151745	0.14829625202222163
KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS	0.00151745	0.14829625202222163
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00151745	0.14829625202222163
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.00151745	0.14829625202222163
DISTAL MONOSOMY 3P	0.00151745	0.14829625202222163
OPTICOCOCHLEODENTATE DEGENERATION	0.00151745	0.14829625202222163
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.00151745	0.14829625202222163
KABUKI SYNDROME 1	0.00151745	0.14829625202222163
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.00151745	0.14829625202222163
SCLEROSTEOSIS 1; SOST1	0.00151745	0.14829625202222163
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00151745	0.14829625202222163
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.00151745	0.14829625202222163
PETERS-PLUS SYNDROME; PTRPLS	0.00151745	0.14829625202222163
DISTAL TRISOMY 14Q	0.00151745	0.14829625202222163
FREEMAN-SHELDON SYNDROME	0.00151745	0.14829625202222163
CRIGLER-NAJJAR SYNDROME	0.00151745	0.14829625202222163
RENAL, GENITAL, AND MIDDLE EAR ANOMALIES	0.00151745	0.14829625202222163
KERATODERMA, PALMOPLANTAR, WITH DEAFNESS	0.00151745	0.14829625202222163
22Q11.2 MICRODUPLICATION SYNDROME	0.00151745	0.14829625202222163
IVIC SYNDROME	0.00151745	0.14829625202222163
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE	0.00151745	0.14829625202222163
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.00151745	0.14829625202222163
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00151745	0.14829625202222163
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.00151745	0.14829625202222163
BROOKE-SPIEGLER SYNDROME	0.00151745	0.14829625202222163
RFT1-CDG	0.00151745	0.14829625202222163
OCULOSKELETODENTAL SYNDROME; OCSKD	0.00151745	0.14829625202222163
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.00151745	0.14829625202222163
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.00151745	0.14829625202222163
DYSCHROMATOSIS UNIVERSALIS HEREDITARIA	0.00151745	0.14829625202222163
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.00151745	0.14829625202222163
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.00151745	0.14829625202222163
ZIMMERMANN-LABAND SYNDROME 1	0.00151745	0.14829625202222163
LOCKED-IN SYNDROME	0.00151745	0.14829625202222163
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.00151745	0.14829625202222163
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.00151745	0.14829625202222163
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.00151745	0.14829625202222163
TAY-SACHS DISEASE	0.00151745	0.14829625202222163
CAMURATI-ENGELMANN DISEASE	0.00151745	0.14829625202222163
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.00151745	0.14829625202222163
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.00151745	0.14829625202222163
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.00151745	0.14829625202222163
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.00151745	0.14829625202222163
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.00151745	0.14829625202222163
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.00151745	0.14829625202222163
OROFACIODIGITAL SYNDROME XVII	0.00151745	0.14829625202222163
CHROMOSOME 1P35 DELETION SYNDROME	0.00151745	0.14829625202222163
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.00151745	0.14829625202222163
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.00151745	0.14829625202222163
DEAFNESS, AUTOSOMAL DOMINANT 74; DFNA74	0.00151745	0.14829625202222163
DEAFNESS, X-LINKED 5; DFNX5	0.00151745	0.14829625202222163
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.00151745	0.14829625202222163
EAR EXOSTOSES	0.00151745	0.14829625202222163
MESOMELIA-SYNOSTOSES SYNDROME	0.00151745	0.14829625202222163
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.00151745	0.14829625202222163
%300719 DEAFNESS, CATARACT, RETINITIS PIGMENTOSA, AND SPERM ABNORMALITIES	0.00151745	0.14829625202222163
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	0.00151745	0.14829625202222163
CRIGLER-NAJJAR SYNDROME TYPE 1	0.00151745	0.14829625202222163
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00151745	0.14829625202222163
BIOTINIDASE DEFICIENCY	0.00151745	0.14829625202222163
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.00151745	0.14829625202222163
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.00151745	0.14829625202222163
MYHRE SYNDROME	0.00151745	0.14829625202222163
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.00151745	0.14829625202222163
BARDET-BIEDL SYNDROME	0.00151745	0.14829625202222163
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.00151745	0.14829625202222163
NARP SYNDROME	0.00151745	0.14829625202222163
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00151745	0.14829625202222163
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 13	0.00151745	0.14829625202222163
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.00151745	0.14829625202222163
SWEENEY-COX SYNDROME; SWCOS	0.00151745	0.14829625202222163
EPIDERMOLYSIS BULLOSA SIMPLEX WITH ANODONTIA/HYPODONTIA	0.00151745	0.14829625202222163
LEBER CONGENITAL AMAUROSIS	0.00151745	0.14829625202222163
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00151745	0.14829625202222163
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00151745	0.14829625202222163
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.00151745	0.14829625202222163
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.00151745	0.14829625202222163
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00151745	0.14829625202222163
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00151745	0.14829625202222163
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00151745	0.14829625202222163
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00151745	0.14829625202222163
4Q21 MICRODELETION SYNDROME	0.00151745	0.14829625202222163
ADRENOLEUKODYSTROPHY	0.00151745	0.14829625202222163
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.00151745	0.14829625202222163
INFANTILE ONSET SPINOCEREBELLAR ATAXIA	0.00151745	0.14829625202222163
STICKLER SYNDROME, TYPE I	0.00150376	0.14695836564034134
ACRO-RENAL-OCULAR SYNDROME	0.00150376	0.14695836564034134
CONGENITAL MYASTHENIC SYNDROME	0.00150376	0.14695836564034134
ARTHROGRYPOSIS-LIKE HAND ANOMALY AND SENSORINEURAL DEAFNESS	0.00150376	0.14695836564034134
KALLMANN SYNDROME	0.00150376	0.14695836564034134
PENDRED SYNDROME	0.00150376	0.14695836564034134
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.00150376	0.14695836564034134
HADDAD SYNDROME	0.00150376	0.14695836564034134
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.00150376	0.14695836564034134
DISTAL MONOSOMY 19P13.3	0.00150376	0.14695836564034134
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.00150376	0.14695836564034134
NAIL-PATELLA SYNDROME	0.00150376	0.14695836564034134
ALPORT SYNDROME	0.00150376	0.14695836564034134
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.00150376	0.14695836564034134
OTODENTAL DYSPLASIA	0.00150376	0.14695836564034134
CEDNIK SYNDROME	0.00150376	0.14695836564034134
SENSORINEURAL HEARING LOSS-EARLY GRAYING-ESSENTIAL TREMOR SYNDROME	0.00150376	0.14695836564034134
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00150376	0.14695836564034134
ALBINISM-DEAFNESS SYNDROME	0.00150376	0.14695836564034134
NOONAN SYNDROME	0.00150376	0.14695836564034134
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00150376	0.14695836564034134
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00150376	0.14695836564034134
NEUROFIBROMATOSIS TYPE 2	0.00150376	0.14695836564034134
ERMINE PHENOTYPE	0.00150376	0.14695836564034134
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.00150376	0.14695836564034134
PANHYPOPHYSITIS	0.00150376	0.14695836564034134
ACUTE BILIRUBIN ENCEPHALOPATHY	0.00150376	0.14695836564034134
MULTIPLE SULFATASE DEFICIENCY	0.00150376	0.14695836564034134
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00150376	0.14695836564034134
PAPILLORENAL SYNDROME	0.00150376	0.14695836564034134
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.00150376	0.14695836564034134
BRITTLE CORNEA SYNDROME	0.00150376	0.14695836564034134
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00150376	0.14695836564034134
RETINITIS PIGMENTOSA	0.00150376	0.14695836564034134
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.00150376	0.14695836564034134
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00150376	0.14695836564034134
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.00150376	0.14695836564034134
WAARDENBURG SYNDROME TYPE 2	0.00150376	0.14695836564034134
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.00150376	0.14695836564034134
CORNELIA DE LANGE SYNDROME 1	0.00150376	0.14695836564034134
VON HIPPEL-LINDAU DISEASE	0.00150376	0.14695836564034134
MELAS	0.00150376	0.14695836564034134
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.00150376	0.14695836564034134
USHER SYNDROME	0.00150376	0.14695836564034134
STICKLER SYNDROME TYPE 1	0.00150376	0.14695836564034134
KERATODERMA HEREDITARIUM MUTILANS WITH ICHTHYOSIS	0.00150376	0.14695836564034134
CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS	0.00150376	0.14695836564034134
TRIPLE A SYNDROME	0.00150376	0.14695836564034134
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.00150376	0.14695836564034134
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.00150376	0.14695836564034134
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.00150376	0.14695836564034134
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00150376	0.14695836564034134
SIALIDOSIS TYPE 1	0.00150376	0.14695836564034134
STICKLER SYNDROME	0.00150376	0.14695836564034134
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.00150376	0.14695836564034134
DEAFNESS, MID-TONE NEURAL	0.00150376	0.14695836564034134
SUSAC SYNDROME	0.00150376	0.14695836564034134
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL DOMINANT 1	0.00150376	0.14695836564034134
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.00150376	0.14695836564034134
STICKLER SYNDROME TYPE 2	0.00150376	0.14695836564034134
KRABBE DISEASE	0.00150376	0.14695836564034134
RELAPSING POLYCHONDRITIS	0.00150376	0.14695836564034134
ADENOHYPOPHYSITIS	0.00150376	0.14695836564034134
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00150376	0.14695836564034134
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00150376	0.14695836564034134
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00150376	0.14695836564034134
RADIO-ULNAR SYNOSTOSIS-AMEGAKARYOCYTIC THROMBOCYTOPENIA SYNDROME	0.00150376	0.14695836564034134
ACROCRANIOFACIAL DYSOSTOSIS	0.00150376	0.14695836564034134
DEAFNESS-INFERTILITY SYNDROME	0.00150376	0.14695836564034134
RENIER-GABREELS-JASPER SYNDROME	0.00150376	0.14695836564034134
MUCOPOLYSACCHARIDOSIS TYPE 2	0.00150376	0.14695836564034134
JUBERG-MARSIDI SYNDROME	0.00150376	0.14695836564034134
HURLER-SCHEIE SYNDROME	0.00150376	0.14695836564034134
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00150376	0.14695836564034134
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.00150376	0.14695836564034134
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00150376	0.14695836564034134
115250 COLLAGENOMA, FAMILIAL CUTANEOUS	0.00150376	0.14695836564034134
MARSHALL SYNDROME	0.00150376	0.14695836564034134
ABRUZZO-ERICKSON SYNDROME	0.00150376	0.14695836564034134
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.00150376	0.14695836564034134
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00150376	0.14695836564034134
STICKLER SYNDROME, TYPE III	0.00150376	0.14695836564034134
SPINOCEREBELLAR ATAXIA 31	0.00150376	0.14695836564034134
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.00150376	0.14695836564034134
ZELLWEGER SYNDROME	0.00150376	0.14695836564034134
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00150376	0.14695836564034134
XERODERMA PIGMENTOSUM	0.00150376	0.14695836564034134
FAMILIAL LONG QT SYNDROME	0.00150376	0.14695836564034134
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00150376	0.14695836564034134
INFANTILE REFSUM DISEASE	0.00150376	0.14695836564034134
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.00150376	0.14695836564034134
KID SYNDROME	0.00150376	0.14695836564034134
KERATODERMA HEREDITARIUM MUTILANS	0.00150376	0.14695836564034134
8Q12 MICRODUPLICATION SYNDROME	0.00150376	0.14695836564034134
FAMILIAL COLD URTICARIA	0.00150376	0.14695836564034134
JOUBERT SYNDROME 21	0.00150376	0.14695836564034134
FRONTOMETAPHYSEAL DYSPLASIA	0.00150376	0.14695836564034134
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.00150376	0.14695836564034134
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.00150376	0.14695836564034134
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.00150376	0.14695836564034134
DEAFNESS, X-LINKED 1	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL RECESSIVE 103; DFNB103	0.00150376	0.14695836564034134
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.00150376	0.14695836564034134
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00150376	0.14695836564034134
COFFIN-LOWRY SYNDROME; CLS	0.00150376	0.14695836564034134
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00150376	0.14695836564034134
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.00150376	0.14695836564034134
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00150376	0.14695836564034134
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00150376	0.14695836564034134
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.00150376	0.14695836564034134
CRANIOSYNOSTOSIS 6; CRS6	0.00150376	0.14695836564034134
OPTIC ATROPHY 8	0.00150376	0.14695836564034134
FABRY DISEASE	0.00150376	0.14695836564034134
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL DOMINANT 69	0.00150376	0.14695836564034134
IMMUNODEFICIENCY 23; IMD23	0.00150376	0.14695836564034134
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL DOMINANT 68	0.00150376	0.14695836564034134
INFANTILE LIVER FAILURE SYNDROME 1	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL DOMINANT 64; DFNA64	0.00150376	0.14695836564034134
%614211 DEAFNESS, AUTOSOMAL DOMINANT 33; DFNA33	0.00150376	0.14695836564034134
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00150376	0.14695836564034134
STICKLER SYNDROME, TYPE V; STL5	0.00150376	0.14695836564034134
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.00150376	0.14695836564034134
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00150376	0.14695836564034134
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00150376	0.14695836564034134
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00150376	0.14695836564034134
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.00150376	0.14695836564034134
PEROXISOME BIOGENESIS DISORDER 5B	0.00150376	0.14695836564034134
PEROXISOME BIOGENESIS DISORDER 6B	0.00150376	0.14695836564034134
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.00150376	0.14695836564034134
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.00150376	0.14695836564034134
PERRAULT SYNDROME 2; PRLTS2	0.00150376	0.14695836564034134
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00150376	0.14695836564034134
STEEL SYNDROME; STLS	0.00150376	0.14695836564034134
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.00150376	0.14695836564034134
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.00150376	0.14695836564034134
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL RECESSIVE 97	0.00150376	0.14695836564034134
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.00150376	0.14695836564034134
RETINITIS PIGMENTOSA 59; RP59	0.00150376	0.14695836564034134
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL RECESSIVE 57; DFNB57	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL RECESSIVE 110; DFNB110	0.00150376	0.14695836564034134
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00150376	0.14695836564034134
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00150376	0.14695836564034134
MENTAL RETARDATION, X-LINKED 46	0.00150376	0.14695836564034134
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.00150376	0.14695836564034134
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.00150376	0.14695836564034134
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.00150376	0.14695836564034134
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.00150376	0.14695836564034134
CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2	0.00150376	0.14695836564034134
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL RECESSIVE 113	0.00150376	0.14695836564034134
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL RECESSIVE 100; DFNB100	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL RECESSIVE 114; DFNB114	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL RECESSIVE 115; DFNB115	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL RECESSIVE 99	0.00150376	0.14695836564034134
NOONAN SYNDROME 11; NS11	0.00150376	0.14695836564034134
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.00150376	0.14695836564034134
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00150376	0.14695836564034134
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.00150376	0.14695836564034134
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.00150376	0.14695836564034134
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.00150376	0.14695836564034134
ALPORT SYNDROME, X-LINKED; ATS	0.00150376	0.14695836564034134
SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY; SFMMP	0.00150376	0.14695836564034134
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.00150376	0.14695836564034134
KEIPERT SYNDROME; KPTS	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL DOMINANT 66	0.00150376	0.14695836564034134
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.00150376	0.14695836564034134
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00150376	0.14695836564034134
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.00150376	0.14695836564034134
THAUVIN-ROBINET-FAIVRE SYNDROME	0.00150376	0.14695836564034134
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.00150376	0.14695836564034134
IMMUNODEFICIENCY 47	0.00150376	0.14695836564034134
CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL	0.00150376	0.14695836564034134
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.00150376	0.14695836564034134
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL DOMINANT 71; DFNA71	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL DOMINANT 72; DFNA72	0.00150376	0.14695836564034134
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.00150376	0.14695836564034134
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00150376	0.14695836564034134
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00150376	0.14695836564034134
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.00150376	0.14695836564034134
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.00150376	0.14695836564034134
MIDDLE EAR NEUROENDOCRINE TUMOR	0.00150376	0.14695836564034134
%607017 DEAFNESS, AUTOSOMAL DOMINANT 21; DFNA21	0.00150376	0.14695836564034134
DYSTONIA, JUVENILE-ONSET	0.00150376	0.14695836564034134
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.00150376	0.14695836564034134
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00150376	0.14695836564034134
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 18	0.00150376	0.14695836564034134
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00150376	0.14695836564034134
CHROMOSOME 1P36 DELETION SYNDROME	0.00150376	0.14695836564034134
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.00150376	0.14695836564034134
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 13	0.00150376	0.14695836564034134
CHROMOSOME 18Q DELETION SYNDROME	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 49	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL DOMINANT 43	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 28	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL DOMINANT 47	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 3	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 12	0.00150376	0.14695836564034134
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.00150376	0.14695836564034134
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00150376	0.14695836564034134
AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1	0.00150376	0.14695836564034134
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00150376	0.14695836564034134
USHER SYNDROME, TYPE IG	0.00150376	0.14695836564034134
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL RECESSIVE 17; DFNB17	0.00150376	0.14695836564034134
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.00150376	0.14695836564034134
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.00150376	0.14695836564034134
STICKLER SYNDROME, TYPE II	0.00150376	0.14695836564034134
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL DOMINANT 23; DFNA23	0.00150376	0.14695836564034134
CARDIOMYOPATHY, DILATED, 1J; CMD1J	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL RECESSIVE 26	0.00150376	0.14695836564034134
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL DOMINANT 25	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL RECESSIVE 14	0.00150376	0.14695836564034134
%605818 DEAFNESS, AUTOSOMAL RECESSIVE 27; DFNB27	0.00150376	0.14695836564034134
SPONDYLOOCULAR SYNDROME; SOS	0.00150376	0.14695836564034134
NEUROENDOCRINE CARCINOMA OF SALIVARY GLANDS, SENSORINEURAL HEARING LOSS, AND ENAMEL HYPOPLASIA	0.00150376	0.14695836564034134
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.00150376	0.14695836564034134
CDAGS SYNDROME	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL RECESSIVE 13	0.00150376	0.14695836564034134
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL DOMINANT 30	0.00150376	0.14695836564034134
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.00150376	0.14695836564034134
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.00150376	0.14695836564034134
DEAFNESS, Y-LINKED 1	0.00150376	0.14695836564034134
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.00150376	0.14695836564034134
HUNTER-MACDONALD SYNDROME	0.00150376	0.14695836564034134
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.00150376	0.14695836564034134
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.00150376	0.14695836564034134
HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL DOMINANT 27	0.00150376	0.14695836564034134
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.00150376	0.14695836564034134
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00150376	0.14695836564034134
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL DOMINANT 59	0.00150376	0.14695836564034134
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.00150376	0.14695836564034134
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.00150376	0.14695836564034134
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.00150376	0.14695836564034134
DEAFNESS, Y-LINKED 2; DFNY2	0.00150376	0.14695836564034134
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00150376	0.14695836564034134
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.00150376	0.14695836564034134
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.00150376	0.14695836564034134
NOONAN SYNDROME 6; NS6	0.00150376	0.14695836564034134
WAARDENBURG SYNDROME, TYPE 4B; WS4B	0.00150376	0.14695836564034134
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N	0.00150376	0.14695836564034134
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.00150376	0.14695836564034134
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 2	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL RECESSIVE 23	0.00150376	0.14695836564034134
BRACHYDACTYLY, TYPE B2	0.00150376	0.14695836564034134
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00150376	0.14695836564034134
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 42	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 10	0.00150376	0.14695836564034134
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00150376	0.14695836564034134
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL RECESSIVE 51	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL DOMINANT 53	0.00150376	0.14695836564034134
DEAFNESS, CHILDHOOD-ONSET NEUROSENSORY, AUTOSOMAL RECESSIVE 8	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL RECESSIVE 9	0.00150376	0.14695836564034134
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 7	0.00150376	0.14695836564034134
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 5	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL RECESSIVE 66; DFNB66	0.00150376	0.14695836564034134
ENLARGED VESTIBULAR AQUEDUCT	0.00150376	0.14695836564034134
DEAFNESS, AUTOSOMAL RECESSIVE 68	0.00150376	0.14695836564034134
HYPERTRYPTOPHANEMIA; HYPTRP	0.00150376	0.14695836564034134
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.00150376	0.14695836564034134
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00150376	0.14695836564034134
CHROMOSOME 2Q37 DELETION SYNDROME	0.00150376	0.14695836564034134
CODAS SYNDROME	0.00150376	0.14695836564034134
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00150376	0.14695836564034134
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.00150376	0.14695836564034134
X-LINKED AGAMMAGLOBULINEMIA	0.00150376	0.14695836564034134
AUTOSOMAL RECESSIVE HYPOPHOSPHATEMIC RICKETS	0.00150376	0.14695836564034134
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00150376	0.14695836564034134
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.00150376	0.14695836564034134
FETAL CYTOMEGALOVIRUS SYNDROME	0.00150376	0.14695836564034134
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.00150376	0.14695836564034134
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.00150376	0.14695836564034134
ACROOTOOCULAR SYNDROME	0.00150376	0.14695836564034134
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.00150376	0.14695836564034134
GALACTOSE EPIMERASE DEFICIENCY	0.00150376	0.14695836564034134
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00150376	0.14695836564034134
FOUNTAIN SYNDROME	0.00150376	0.14695836564034134
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.00150376	0.14695836564034134
SCLEROSTEOSIS	0.00150376	0.14695836564034134
ERMINE PHENOTYPE	0.00150376	0.14695836564034134
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.00150376	0.14695836564034134
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.00150376	0.14695836564034134
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00150376	0.14695836564034134
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.00150376	0.14695836564034134
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00150376	0.14695836564034134
HEARING LOSS-FAMILIAL SALIVARY GLAND INSENSITIVITY TO ALDOSTERONE SYNDROME	0.00150376	0.14695836564034134
CONGENITAL RUBELLA SYNDROME	0.00150376	0.14695836564034134
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.00150376	0.14695836564034134
DEAFNESS-OLIGODONTIA SYNDROME	0.00150376	0.14695836564034134
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.00150376	0.14695836564034134
NATHALIE SYNDROME	0.00150376	0.14695836564034134
NEPHROPATHY-DEAFNESS-HYPERPARATHYROIDISM SYNDROME	0.00150376	0.14695836564034134
FACIOSCAPULOHUMERAL DYSTROPHY	0.00150376	0.14695836564034134
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.00150376	0.14695836564034134
KNUCKLE PADS-LEUKONYCHIA-SENSORINEURAL DEAFNESS-PALMOPLANTAR HYPERKERATOSIS SYNDROME	0.00150376	0.14695836564034134
OCULOFACIOCARDIODENTAL SYNDROME	0.00150376	0.14695836564034134
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00150376	0.14695836564034134
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.00150376	0.14695836564034134
OPITZ G/BBB SYNDROME	0.00150376	0.14695836564034134
VICI SYNDROME; VICIS	0.00150376	0.14695836564034134
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00150376	0.14695836564034134
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE	0.00150376	0.14695836564034134
LATERAL MENINGOCELE SYNDROME	0.00150376	0.14695836564034134
ENDOSTEAL HYPEROSTOSIS, WORTH TYPE	0.00150376	0.14695836564034134
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00150376	0.14695836564034134
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00150376	0.14695836564034134
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00150376	0.14695836564034134
STIFF SKIN SYNDROME	0.00150376	0.14695836564034134
RENAL CALICEAL DIVERTICULI-DEAFNESS SYNDROME	0.00150376	0.14695836564034134
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00150376	0.14695836564034134
ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS	0.00150376	0.14695836564034134
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.00150376	0.14695836564034134
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00150376	0.14695836564034134
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.00150376	0.14695836564034134
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.00150376	0.14695836564034134
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.00150376	0.14695836564034134
SALT-AND-PEPPER SYNDROME	0.00150376	0.14695836564034134
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00150376	0.14695836564034134
HIRSCHSPRUNG DISEASE	0.00150376	0.14695836564034134
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.00150376	0.14695836564034134
MICROPHTHALMIA, SYNDROMIC 3	0.00150376	0.14695836564034134
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00150376	0.14695836564034134
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00150376	0.14695836564034134
3P25.3 MICRODELETION SYNDROME	0.00150376	0.14695836564034134
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00150376	0.14695836564034134
ACROCRANIOFACIAL DYSOSTOSIS	0.00150376	0.14695836564034134
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.00150376	0.14695836564034134
WT LIMB-BLOOD SYNDROME	0.00150376	0.14695836564034134
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.00150376	0.14695836564034134
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.00150376	0.14695836564034134
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.00150376	0.14695836564034134
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.00150376	0.14695836564034134
SPINOCEREBELLAR ATAXIA TYPE 37	0.00150376	0.14695836564034134
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.00150376	0.14695836564034134
DEAFNESS-VITILIGO-ACHALASIA SYNDROME	0.00150376	0.14695836564034134
ACROCALLOSAL SYNDROME	0.00150376	0.14695836564034134
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00150376	0.14695836564034134
PROXIMAL SYMPHALANGISM	0.00150376	0.14695836564034134
%223200 DISORGANIZATION, MOUSE, HOMOLOG OF;;DS	0.00150376	0.14695836564034134
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.00150376	0.14695836564034134
THYROCEREBRORENAL SYNDROME	0.00150376	0.14695836564034134
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.00150376	0.14695836564034134
DEAFNESS, NEURAL, WITH ATYPICAL ATOPIC DERMATITIS	0.00150376	0.14695836564034134
DEAFNESS, NEURAL, CONGENITAL MODERATE	0.00150376	0.14695836564034134
DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL ANDPROGRESSIVE SENSORY NEUROPATHY	0.00150376	0.14695836564034134
HYPEROSTOSIS CORTICALIS GENERALISATA	0.00150376	0.14695836564034134
VOGT-KOYANAGI-HARADA DISEASE	0.00150376	0.14695836564034134
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.00150376	0.14695836564034134
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00150376	0.14695836564034134
WORSTER-DROUGHT SYNDROME	0.00150376	0.14695836564034134
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.00150376	0.14695836564034134
CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	0.00150376	0.14695836564034134
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.00150376	0.14695836564034134
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.00150376	0.14695836564034134
COCKAYNE SYNDROME A; CSA	0.00150376	0.14695836564034134
KEIPERT SYNDROME	0.00150376	0.14695836564034134
COG5-CDG	0.00150376	0.14695836564034134
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 24	0.00150376	0.14695836564034134
CATARACT-DEAFNESS-HYPOGONADISM SYNDROME	0.00150376	0.14695836564034134
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.00150376	0.14695836564034134
CINCA SYNDROME	0.00150376	0.14695836564034134
CODAS SYNDROME	0.00150376	0.14695836564034134
COFS SYNDROME	0.00150376	0.14695836564034134
COGAN SYNDROME	0.00150376	0.14695836564034134
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00150376	0.14695836564034134
CORNEAL DYSTROPHY-PERCEPTIVE DEAFNESS SYNDROME	0.00150376	0.14695836564034134
VICI SYNDROME	0.00150376	0.14695836564034134
SPONDYLOPERIPHERAL DYSPLASIA	0.00150376	0.14695836564034134
CRANIOMETAPHYSEAL DYSPLASIA	0.00150376	0.14695836564034134
CRANIOFACIAL-DEAFNESS-HAND SYNDROME	0.00150376	0.14695836564034134
FAMILIAL ISOLATED DILATED CARDIOMYOPATHY	0.00150376	0.14695836564034134
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.00150376	0.14695836564034134
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.00150376	0.14695836564034134
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.00150376	0.14695836564034134
1P36 DELETION SYNDROME	0.00150376	0.14695836564034134
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.00150376	0.14695836564034134
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.00150376	0.14695836564034134
AUTOSOMAL DOMINANT OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00150376	0.14695836564034134
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.00150376	0.14695836564034134
MADRAS MOTOR NEURON DISEASE	0.00150376	0.14695836564034134
RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS	0.00150376	0.14695836564034134
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.00150376	0.14695836564034134
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 27	0.00150376	0.14695836564034134
DEAFNESS, X-LINKED 4	0.00150376	0.14695836564034134
DE SANCTIS-CACCHIONE SYNDROME	0.00150376	0.14695836564034134
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00150376	0.14695836564034134
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00150376	0.14695836564034134
ARTHROGRYPOSIS-LIKE HAND ANOMALY-SENSORINEURAL DEAFNESS SYNDROME	0.00150376	0.14695836564034134
WAARDENBURG-SHAH SYNDROME	0.00150376	0.14695836564034134
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.00150376	0.14695836564034134
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.00150376	0.14695836564034134
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00150376	0.14695836564034134
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.00150376	0.14695836564034134
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00150376	0.14695836564034134
USHER SYNDROME, TYPE IIIA	0.00150376	0.14695836564034134
BJÖRNSTAD SYNDROME	0.00150376	0.14695836564034134
CHANARIN-DORFMAN SYNDROME	0.00150376	0.14695836564034134
FEINGOLD SYNDROME	0.00150376	0.14695836564034134
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00150376	0.14695836564034134
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.00150376	0.14695836564034134
THYROCEREBRORETINAL SYNDROME	0.00150376	0.14695836564034134
ROTHMUND-THOMSON SYNDROME	0.00150376	0.14695836564034134
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.00150376	0.14695836564034134
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.00150376	0.14695836564034134
256120 NEPHROPATHY, DEAFNESS, AND HYPERPARATHYROIDISM	0.00150376	0.14695836564034134
NASODIGITOACOUSTIC SYNDROME	0.00150376	0.14695836564034134
USHER SYNDROME TYPE 1	0.00150376	0.14695836564034134
USHER SYNDROME TYPE 2	0.00150376	0.14695836564034134
USHER SYNDROME TYPE 3	0.00150376	0.14695836564034134
NON-ACQUIRED COMBINED PITUITARY HORMONE DEFICIENCY-SENSORINEURAL HEARING LOSS-SPINE ABNORMALITIES SYNDROME	0.00150376	0.14695836564034134
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.00150376	0.14695836564034134
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.00150376	0.14695836564034134
LAURENCE-MOON SYNDROME	0.00150376	0.14695836564034134
ISOLATED SPLIT HAND-SPLIT FOOT MALFORMATION	0.00150376	0.14695836564034134
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.00150376	0.14695836564034134
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.00150376	0.14695836564034134
1Q21.1 MICRODELETION SYNDROME	0.00150376	0.14695836564034134
MULTIPLE EPIPHYSEAL DYSPLASIA	0.00150376	0.14695836564034134
6Q25 MICRODELETION SYNDROME	0.00150376	0.14695836564034134
19P13.12 MICRODELETION SYNDROME	0.00150376	0.14695836564034134
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.00150376	0.14695836564034134
MOYNAHAN SYNDROME	0.00150376	0.14695836564034134
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.00150376	0.14695836564034134
MYOPATHY AND DIABETES MELLITUS	0.00150376	0.14695836564034134
LEIGH SYNDROME; LS	0.00150376	0.14695836564034134
NEURAMINIDASE DEFICIENCY	0.00150376	0.14695836564034134
AMISH INFANTILE EPILEPSY SYNDROME	0.00150376	0.14695836564034134
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00150376	0.14695836564034134
PEROXISOME BIOGENESIS DISORDER 3B	0.00150376	0.14695836564034134
REFSUM DISEASE	0.00150376	0.14695836564034134
MYH9-RELATED DISEASE	0.00150376	0.14695836564034134
FRONTOMETAPHYSEAL DYSPLASIA	0.00150376	0.14695836564034134
SEVERE COMBINED IMMUNODEFICIENCY	0.00150376	0.14695836564034134
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.00150376	0.14695836564034134
EEC SYNDROME	0.00150376	0.14695836564034134
COCKAYNE SYNDROME	0.00150376	0.14695836564034134
FETAL IODINE SYNDROME	0.00150376	0.14695836564034134
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.00150376	0.14695836564034134
PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, ANDDEAFNESS	0.00150376	0.14695836564034134
CORNELIA DE LANGE SYNDROME	0.00150376	0.14695836564034134
EAST SYNDROME	0.00150376	0.14695836564034134
CRANDALL SYNDROME	0.00150376	0.14695836564034134
GINGIVAL FIBROMATOSIS-PROGRESSIVE DEAFNESS SYNDROME	0.00150376	0.14695836564034134
GEMIGNANI SYNDROME	0.00150376	0.14695836564034134
DONNAI-BARROW SYNDROME	0.00150376	0.14695836564034134
HIRSCHSPRUNG DISEASE-DEAFNESS-POLYDACTYLY SYNDROME	0.00150376	0.14695836564034134
PALMOPLANTAR KERATODERMA-DEAFNESS SYNDROME	0.00150376	0.14695836564034134
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.00150376	0.14695836564034134
